CHEBI ONTOLOGY - ANNOTATIONS |
|
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
|
Term: | tropane alkaloid |
|
Accession: | CHEBI:37332
|
browse the term
|
Synonyms: | related_synonym: | tropane alkaloids |
| alt_id: | CHEBI:27154; CHEBI:27155 |
|
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Hyoscyamine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,584,189...12,628,489
Ensembl chr17:12,584,132...12,628,488
|
|
|
G |
Chrna7 |
cholinergic receptor, nicotinic, alpha polypeptide 7 |
multiple interactions |
ISO |
anatoxin a inhibits the reaction [iodo-alpha-bungarotoxin binds to CHRNA7 protein] |
CTD |
PMID:19448648 |
|
NCBI chr 7:63,098,692...63,212,526
Ensembl chr 7:63,098,692...63,212,569
|
|
|
G |
Abcb11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
multiple interactions decreases activity |
ISO |
Atropine inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] Atropine results in decreased activity of ABCB11 protein |
CTD |
PMID:24014644 |
|
NCBI chr 2:69,238,282...69,342,616
Ensembl chr 2:69,238,282...69,342,616
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
multiple interactions |
ISO |
[Parathion co-treated with Atropine] results in increased expression of ABL1 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 2:31,688,244...31,807,093
Ensembl chr 2:31,688,376...31,804,227
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO EXP |
Atropine inhibits the reaction [[Organophosphorus Compounds results in decreased activity of ACHE protein] which results in increased abundance of Acetylcholine]; Atropine inhibits the reaction [Carbachol results in increased metabolism of and results in increased secretion of ACHE protein]; Atropine inhibits the reaction [Paraoxon results in increased expression of ACHE protein] [Atropine co-treated with Obidoxime Chloride] inhibits the reaction [Paraoxon results in decreased activity of ACHE protein]; [Methyl Parathion co-treated with pralidoxime co-treated with Atropine] results in decreased expression of ACHE protein; [Paraoxon co-treated with pralidoxime co-treated with Atropine] results in decreased activity of ACHE protein; [pralidoxime co-treated with Atropine] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]; [tariquidar co-treated with asoxime chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; Atropine inhibits the reaction [Methyl Parathion results in decreased activity of ACHE protein]; Obidoxime Chloride inhibits the reaction [[Paraoxon co-treated with pralidoxime co-treated with Atropine] results in decreased activity of ACHE protein]; pralidoxime promotes the reaction [[Atropine co-treated with Curcumin] inhibits the reaction [Dichlorvos results in decreased activity of ACHE protein]] [1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [[1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium) propane dibromide co-treated with cucurbit(7)uril] co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; Atropine inhibits the reaction [Sarin results in decreased activity of ACHE protein]; Atropine promotes the reaction [Dichlorvos results in increased phosphorylation of ACHE protein]; Atropine promotes the reaction [haloxon results in increased phosphorylation of ACHE protein]; Atropine promotes the reaction [Paraoxon results in increased phosphorylation of ACHE protein] |
CTD |
PMID:2241428 PMID:10421444 PMID:17963125 PMID:20105433 PMID:21600273 PMID:21787676 PMID:22783142 PMID:23047022 PMID:24881594 PMID:26751814 PMID:31794810 |
|
NCBI chr 5:137,288,247...137,294,466
Ensembl chr 5:137,287,519...137,294,466
|
|
G |
Adcy5 |
adenylate cyclase 5 |
increases response to substance |
EXP |
ADCY5 protein results in increased susceptibility to Atropine |
CTD |
PMID:12869393 |
|
NCBI chr16:35,154,494...35,305,743
Ensembl chr16:35,154,877...35,305,738
|
|
G |
Aqp5 |
aquaporin 5 |
multiple interactions |
EXP |
Atropine inhibits the reaction [Pilocarpine affects the localization of AQP5 protein] |
CTD |
PMID:26208470 |
|
NCBI chr15:99,591,028...99,594,829
Ensembl chr15:99,590,782...99,594,829
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the expression of BAX mRNA] |
CTD |
PMID:21971501 |
|
NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
|
|
G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of BCAR1 protein]] |
CTD |
PMID:10537051 |
|
NCBI chr 8:111,710,474...111,743,849
Ensembl chr 8:111,710,474...111,743,809
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
[Atropine co-treated with pralidoxime] results in decreased expression of BCHE protein; [Methyl Parathion co-treated with pralidoxime co-treated with Atropine] results in decreased expression of BCHE protein [BCHE protein co-treated with asoxime chloride co-treated with pro-diazepam co-treated with Atropine] results in decreased susceptibility to VX |
CTD |
PMID:17963125 PMID:22981459 |
|
NCBI chr 3:73,635,805...73,708,436
Ensembl chr 3:73,635,808...73,708,415
|
|
G |
Bdkrb2 |
bradykinin receptor, beta 2 |
multiple interactions |
EXP |
BDKRB2 affects the susceptibility to [Propranolol co-treated with Atropine] |
CTD |
PMID:10614985 |
|
NCBI chr12:105,563,172...105,595,244
Ensembl chr12:105,563,226...105,595,237
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Carbon Tetrachloride results in increased expression of BMP6 mRNA] |
CTD |
PMID:18472332 |
|
NCBI chr13:38,345,716...38,500,314
Ensembl chr13:38,345,107...38,500,302
|
|
G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
multiple interactions |
ISO |
Atropine inhibits the reaction [Methacholine Chloride affects the reaction [CACNA1E protein results in increased transport of Barium]] |
CTD |
PMID:12663092 |
|
NCBI chr 1:154,390,806...154,884,785
Ensembl chr 1:154,390,731...154,884,501
|
|
G |
Calca |
calcitonin/calcitonin-related polypeptide, alpha |
affects activity |
ISO |
Atropine affects the activity of CALCA protein |
CTD |
PMID:7906887 PMID:10075105 |
|
NCBI chr 7:114,625,981...114,636,910
Ensembl chr 7:114,631,478...114,636,357
|
|
G |
Casp3 |
caspase 3 |
increases expression |
ISO |
Atropine results in increased expression of CASP3 mRNA |
CTD |
PMID:19815060 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CCL5 protein] |
CTD |
PMID:22245128 |
|
NCBI chr11:83,525,778...83,530,518
Ensembl chr11:83,525,778...83,530,518
|
|
G |
Ccna1 |
cyclin A1 |
increases expression multiple interactions |
ISO |
Atropine results in increased expression of CCNA1 mRNA [Parathion co-treated with Atropine] results in increased expression of CCNA1 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 3:55,045,469...55,057,634
Ensembl chr 3:55,045,469...55,055,501
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
[Parathion co-treated with Atropine] results in increased expression of CCND3 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr17:47,505,051...47,599,689
Ensembl chr17:47,505,051...47,599,691
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions |
ISO |
Atropine results in increased expression of CCNE1 mRNA [Parathion co-treated with Atropine] results in increased expression of CCNE1 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 7:38,097,984...38,107,490
Ensembl chr 7:38,097,984...38,107,534
|
|
G |
Ccne2 |
cyclin E2 |
multiple interactions increases expression |
ISO |
[Parathion co-treated with Atropine] results in increased expression of CCNE2 mRNA Atropine results in increased expression of CCNE2 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 4:11,190,433...11,204,779
Ensembl chr 4:11,191,351...11,204,779
|
|
G |
Cd40 |
CD40 antigen |
multiple interactions |
ISO |
Atropine inhibits the reaction [Carbachol results in increased expression of CD40 protein] |
CTD |
PMID:16879495 |
|
NCBI chr 2:165,055,614...165,071,654
Ensembl chr 2:165,055,627...165,072,948
|
|
G |
Cdc20 |
cell division cycle 20 |
multiple interactions increases expression |
ISO |
[Parathion co-treated with Atropine] results in increased expression of CDC20 mRNA Atropine results in increased expression of CDC20 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 4:118,432,901...118,437,343
Ensembl chr 4:118,432,901...118,437,352
|
|
G |
Cdc6 |
cell division cycle 6 |
multiple interactions |
ISO |
[Parathion co-treated with Atropine] results in increased expression of CDC6 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr11:98,907,709...98,923,942
Ensembl chr11:98,907,801...98,923,940
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions increases expression |
ISO |
[Parathion co-treated with Atropine] results in increased expression of CDK1 mRNA Atropine results in increased expression of CDK1 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr10:69,335,146...69,352,912
Ensembl chr10:69,335,146...69,352,938
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions |
ISO |
Atropine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-methylumbelliferyl acetate] |
CTD |
PMID:9311626 |
|
NCBI chr 8:93,166,072...93,197,804
Ensembl chr 8:93,166,068...93,197,838
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1, CNS |
multiple interactions decreases activity |
EXP ISO |
Atropine binds to and results in decreased activity of CHRM1 protein; Atropine inhibits the reaction [[Carbachol results in increased activity of CHRM1 protein] which results in increased abundance of Calcium] Atropine results in decreased activity of CHRM1 protein Atropine affects the reaction [muscarinic toxin 7 binds to CHRM1 protein] |
CTD |
PMID:16439611 PMID:18316702 PMID:31830555 |
|
NCBI chr19:8,664,005...8,683,606
Ensembl chr19:8,663,789...8,683,587
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2, cardiac |
multiple interactions |
ISO |
Atropine binds to and results in decreased activity of CHRM2 protein |
CTD |
PMID:15140916 |
|
NCBI chr 6:36,387,991...36,528,638
Ensembl chr 6:36,388,084...36,528,414
|
|
G |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
multiple interactions decreases activity |
ISO |
Atropine binds to and results in decreased activity of CHRM3 protein; Atropine inhibits the reaction [Carbachol results in increased activity of CHRM3 protein] Atropine results in decreased activity of CHRM3 protein |
CTD |
PMID:15140916 PMID:20708676 PMID:31830555 |
|
NCBI chr13:9,875,486...10,361,062
Ensembl chr13:9,875,486...10,360,847
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
multiple interactions affects binding |
ISO |
[WIN 62577 co-treated with Quinuclidinyl Benzilate] inhibits the reaction [Atropine binds to CHRM4 protein] |
CTD |
PMID:16709648 |
|
NCBI chr 2:91,922,189...91,929,835
Ensembl chr 2:91,927,249...91,928,688
|
|
G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Acetylcholine results in increased activity of CHRM5 protein] |
CTD |
PMID:31323226 |
|
NCBI chr 2:112,478,733...112,536,361
Ensembl chr 2:112,479,171...112,480,769
|
|
G |
Chrna4 |
cholinergic receptor, nicotinic, alpha polypeptide 4 |
multiple interactions affects binding |
ISO |
Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNA4 protein]] Atropine binds to [CHRNA4 protein binds to CHRNB2 protein] |
CTD |
PMID:15733544 PMID:21791372 |
|
NCBI chr 2:181,022,311...181,043,579
Ensembl chr 2:181,018,380...181,043,546
|
|
G |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
affects binding multiple interactions |
ISO |
Atropine binds to [CHRNA4 protein binds to CHRNB2 protein] Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNB2 mRNA]]; Atropine promotes the reaction [Mecamylamine inhibits the reaction [Paraoxon results in decreased expression of CHRNB2 protein]] Atropine promotes the reaction [Acetylcholine affects the activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:15733544 PMID:21791372 |
|
NCBI chr 3:89,753,448...89,764,632
Ensembl chr 3:89,746,195...89,764,632
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the phosphorylation of CREB1 protein] |
CTD |
PMID:21971501 |
|
NCBI chr 1:64,532,794...64,604,548
Ensembl chr 1:64,532,645...64,604,548
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
ISO |
Atropine inhibits the reaction [acephate results in increased expression of CRH mRNA]; Atropine inhibits the reaction [acephate results in increased secretion of CRH protein]; Atropine inhibits the reaction [methamidophos results in increased expression of CRH mRNA]; Atropine inhibits the reaction [methamidophos results in increased secretion of CRH protein] [Atropine co-treated with SR 140333 co-treated with SR 48968] results in decreased activity of CRH protein |
CTD |
PMID:12039681 PMID:12906840 |
|
NCBI chr 3:19,693,401...19,695,396
Ensembl chr 3:19,693,401...19,695,396
|
|
G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein mutant form]; Atropine inhibits the reaction [Parathion results in increased expression of CTNNB1 protein] |
CTD |
PMID:17390078 |
|
NCBI chr 9:120,933,400...120,960,507
Ensembl chr 9:120,929,216...120,960,507
|
|
G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CXCL1 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of CXCL1 protein] |
CTD |
PMID:22245128 |
|
NCBI chr 5:90,786,101...90,788,093
Ensembl chr 5:90,786,103...90,789,600
|
|
G |
Dvl2 |
dishevelled segment polarity protein 2 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of DVL2 protein] |
CTD |
PMID:17390078 |
|
NCBI chr11:70,000,592...70,010,109
Ensembl chr11:70,000,595...70,012,301
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
EDN1 protein results in decreased activity of [Atropine co-treated with Histamine] |
CTD |
PMID:12906840 |
|
NCBI chr13:42,301,476...42,307,990
Ensembl chr13:42,301,476...42,307,990
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of EGFR protein] |
CTD |
PMID:17390078 |
|
NCBI chr11:16,752,203...16,913,907
Ensembl chr11:16,752,203...16,918,158
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] |
CTD |
PMID:7968354 |
|
NCBI chr18:34,861,207...34,864,956
Ensembl chr18:34,859,823...34,864,984
|
|
G |
Egr2 |
early growth response 2 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR2 mRNA] |
CTD |
PMID:7968354 |
|
NCBI chr10:67,534,469...67,542,188
Ensembl chr10:67,535,475...67,542,188
|
|
G |
Ezr |
ezrin |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of EZR protein] |
CTD |
PMID:17390078 |
|
NCBI chr17:6,738,131...6,782,780
Ensembl chr17:6,738,041...6,782,784
|
|
G |
F2 |
coagulation factor II |
multiple interactions |
EXP |
[Paraoxon co-treated with Atropine co-treated with Obidoxime Chloride] results in decreased expression of F2 mRNA; [Paraoxon co-treated with Atropine co-treated with Obidoxime Chloride] results in increased activity of F2 protein |
CTD |
PMID:30515700 |
|
NCBI chr 2:91,612,397...91,636,457
Ensembl chr 2:91,625,320...91,636,414
|
|
G |
F2r |
coagulation factor II (thrombin) receptor |
multiple interactions |
EXP |
[Paraoxon co-treated with Atropine co-treated with Obidoxime Chloride] results in increased expression of F2R protein |
CTD |
PMID:30515700 |
|
NCBI chr13:95,601,780...95,618,466
Ensembl chr13:95,601,803...95,618,487
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
increases expression multiple interactions |
ISO |
Atropine results in increased expression of FOS protein Atropine inhibits the reaction [Paraoxon results in increased expression of FOS mRNA] [asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased expression of FOS protein]; Atropine inhibits the reaction [Pilocarpine results in increased expression of FOS mRNA] |
CTD |
PMID:7968354 PMID:8281324 PMID:21787676 PMID:21971501 |
|
NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
|
|
G |
Ghrl |
ghrelin |
multiple interactions |
ISO |
Atropine inhibits the reaction [[Pentobarbital co-treated with L-pyroglutamyl-L-histidyl-3,3-dimethylprolinamide] results in increased expression of GHRL protein] |
CTD |
PMID:16959836 |
|
NCBI chr 6:113,716,119...113,719,911
Ensembl chr 6:113,716,119...113,719,880
|
|
G |
Glra1 |
glycine receptor, alpha 1 subunit |
multiple interactions |
ISO |
Atropine binds to and results in decreased activity of GLRA1 protein |
CTD |
PMID:15081878 |
|
NCBI chr11:55,514,239...55,608,198
Ensembl chr11:55,514,238...55,608,198
|
|
G |
Grm4 |
glutamate receptor, metabotropic 4 |
multiple interactions |
ISO |
Atropine inhibits the reaction [[Carbachol results in increased activity of [GRM4 protein binds to KCNJ3 protein]] which results in increased import of Thallium] |
CTD |
PMID:18171729 |
|
NCBI chr17:27,422,387...27,513,826
Ensembl chr17:27,422,387...27,521,403
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of ICAM1 mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of ICAM1 protein] |
CTD |
PMID:22245128 |
|
NCBI chr 9:21,015,940...21,028,814
Ensembl chr 9:21,015,985...21,028,817
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of IL1B mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of IL1B protein] |
CTD |
PMID:22245128 |
|
NCBI chr 2:129,364,569...129,371,164
Ensembl chr 2:129,364,570...129,371,139
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
[Atropine co-treated with Ketamine] inhibits the reaction [Soman results in increased expression of IL6 mRNA]; [Atropine co-treated with Ketamine] inhibits the reaction [Soman results in increased expression of IL6 protein] |
CTD |
PMID:22245128 |
|
NCBI chr 5:30,013,114...30,019,975
Ensembl chr 5:30,013,114...30,019,981
|
|
G |
Jun |
jun proto-oncogene |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the phosphorylation of JUN protein] |
CTD |
PMID:21971501 |
|
NCBI chr 4:95,049,036...95,052,222
Ensembl chr 4:95,049,034...95,052,222
|
|
G |
Junb |
jun B proto-oncogene |
multiple interactions |
ISO |
Atropine inhibits the reaction [Pilocarpine results in increased expression of JUNB mRNA] |
CTD |
PMID:7968354 |
|
NCBI chr 8:84,976,909...84,978,748
Ensembl chr 8:84,974,484...84,978,718 Ensembl chr 8:84,974,484...84,978,718
|
|
G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
multiple interactions |
ISO |
Atropine inhibits the reaction [[Carbachol results in increased activity of [GRM4 protein binds to KCNJ3 protein]] which results in increased import of Thallium] |
CTD |
PMID:18171729 |
|
NCBI chr 2:55,411,798...55,598,145
Ensembl chr 2:55,435,970...55,598,145
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of KIT protein] |
CTD |
PMID:17390078 |
|
NCBI chr 5:75,574,987...75,656,722
Ensembl chr 5:75,574,916...75,656,722
|
|
G |
Ltf |
lactotransferrin |
multiple interactions |
ISO |
Atropine inhibits the reaction [methylcholine results in increased secretion of LTF protein] |
CTD |
PMID:11112886 |
|
NCBI chr 9:111,019,292...111,042,766
Ensembl chr 9:111,019,271...111,042,767
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:21971501 |
|
NCBI chr16:16,983,382...17,047,453
Ensembl chr16:16,983,382...17,047,453
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:21971501 |
|
NCBI chr17:28,691,342...28,748,405
Ensembl chr17:28,691,329...28,748,406
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:21971501 |
|
NCBI chr 7:126,759,626...126,765,816
Ensembl chr 7:126,759,601...126,765,819
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:21971501 |
|
NCBI chr14:33,377,898...33,447,353
Ensembl chr14:33,377,898...33,447,158
|
|
G |
Mcm4 |
minichromosome maintenance complex component 4 |
multiple interactions increases expression |
ISO |
[Parathion co-treated with Atropine] results in increased expression of MCM4 mRNA Atropine results in increased expression of MCM4 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr16:15,623,897...15,637,400
Ensembl chr16:15,623,897...15,637,400
|
|
G |
Mcm6 |
minichromosome maintenance complex component 6 |
increases expression multiple interactions |
ISO |
Atropine results in increased expression of MCM6 mRNA [Parathion co-treated with Atropine] results in increased expression of MCM6 mRNA |
CTD |
PMID:17390078 |
|
NCBI chr 1:128,331,575...128,359,705
Ensembl chr 1:128,331,590...128,359,664
|
|
G |
Nefh |
neurofilament, heavy polypeptide |
affects expression |
ISO |
Atropine affects the expression of NEFH mRNA |
CTD |
PMID:22954530 |
|
NCBI chr11:4,938,754...4,948,064
Ensembl chr11:4,938,754...4,948,064
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
increases expression |
ISO |
Atropine results in increased expression of NLRP3 mRNA |
CTD |
PMID:28138970 |
|
NCBI chr11:59,541,569...59,566,955
Ensembl chr11:59,541,568...59,566,956
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
ISO |
Atropine inhibits the reaction [Indomethacin results in increased activity of NOS2 protein]; Atropine inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA] |
CTD |
PMID:15610444 PMID:16944022 |
|
NCBI chr11:78,920,787...78,960,226
Ensembl chr11:78,920,787...78,960,254
|
|
G |
Notch4 |
notch 4 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of NOTCH4 protein] |
CTD |
PMID:17390078 |
|
NCBI chr17:34,564,286...34,588,543
Ensembl chr17:34,564,268...34,588,503
|
|
G |
Nppa |
natriuretic peptide type A |
affects activity |
ISO |
Atropine affects the activity of NPPA protein modified form |
CTD |
PMID:1363893 |
|
NCBI chr 4:148,000,722...148,002,074
Ensembl chr 4:148,000,722...148,002,079
|
|
G |
Oprl1 |
opioid receptor-like 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [PNOC protein binds to and results in increased activity of OPRL1 protein] |
CTD |
PMID:12007927 |
|
NCBI chr 2:181,715,000...181,720,985
Ensembl chr 2:181,715,016...181,720,985
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
ISO |
Atropine inhibits the reaction [Malathion results in increased expression of PCNA]; Atropine inhibits the reaction [Parathion results in increased expression of PCNA] |
CTD |
PMID:12762645 |
|
NCBI chr 2:132,249,286...132,253,180
Ensembl chr 2:132,249,162...132,253,314
|
|
G |
Pnoc |
prepronociceptin |
multiple interactions |
ISO |
Atropine inhibits the reaction [PNOC protein binds to and results in increased activity of OPRL1 protein] |
CTD |
PMID:12007927 |
|
NCBI chr14:65,400,673...65,425,564
Ensembl chr14:65,400,673...65,425,472
|
|
G |
Pomc |
pro-opiomelanocortin-alpha |
multiple interactions |
ISO |
Atropine inhibits the reaction [Acetylcholine results in increased expression of POMC protein] |
CTD |
PMID:7588217 |
|
NCBI chr12:3,954,945...3,960,643
Ensembl chr12:3,954,951...3,960,642
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
EXP |
[Atropine co-treated with Glucose] binds to PPARA protein; Atropine inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]] |
CTD |
PMID:18812576 |
|
NCBI chr15:85,734,910...85,806,851
Ensembl chr15:85,734,983...85,802,819
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
Atropine affects the reaction [Indomethacin results in increased expression of PTGS2]; Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2 mRNA]; Atropine inhibits the reaction [Indomethacin results in increased expression of PTGS2]; Atropine inhibits the reaction [SC 560 results in increased expression of PTGS2 mRNA] |
CTD |
PMID:15104355 PMID:15610444 PMID:16259740 PMID:16804302 |
|
NCBI chr 1:150,100,031...150,108,234
Ensembl chr 1:150,100,031...150,108,227
|
|
G |
Ptk2 |
PTK2 protein tyrosine kinase 2 |
multiple interactions |
ISO |
Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with lysophosphatidic acid] results in increased phosphorylation of PTK2 protein]]; Atropine inhibits the reaction [oxotremorine M inhibits the reaction [[wortmannin co-treated with oxophenylarsine] results in increased phosphorylation of PTK2 protein]]; Atropine inhibits the reaction [oxotremorine M promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with wortmannin] results in increased phosphorylation of PTK2 protein]] |
CTD |
PMID:10537051 |
|
NCBI chr15:73,205,102...73,423,820
Ensembl chr15:73,205,102...73,423,280
|
|
G |
Pxn |
paxillin |
multiple interactions |
ISO |
Atropine inhibits the reaction [[oxotremorine M co-treated with wortmannin] inhibits the reaction [oxophenylarsine results in increased phosphorylation of PXN protein]] |
CTD |
PMID:10537051 |
|
NCBI chr 5:115,491,970...115,555,987
Ensembl chr 5:115,506,676...115,555,987
|
|
G |
Rac3 |
Rac family small GTPase 3 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of RAC3 protein] |
CTD |
PMID:17390078 |
|
NCBI chr11:120,721,468...120,723,969
Ensembl chr11:120,721,470...120,723,969
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
[asoxime chloride co-treated with Atropine co-treated with Diazepam] affects the reaction [Soman affects the phosphorylation of RELA protein] |
CTD |
PMID:21971501 |
|
NCBI chr19:5,637,442...5,648,134
Ensembl chr19:5,637,483...5,648,130
|
|
G |
Rhoa |
ras homolog family member A |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of RHOA protein] |
CTD |
PMID:17390078 |
|
NCBI chr 9:108,306,160...108,337,943
Ensembl chr 9:108,306,129...108,337,934
|
|
G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [SLC22A1 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Atropine inhibits the reaction [SLC22A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:16263091 PMID:21641380 |
|
NCBI chr17:12,648,874...12,675,838
Ensembl chr17:12,648,869...12,675,829
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Atropine inhibits the reaction [SLC22A2 protein results in increased transport of 1-Methyl-4-phenylpyridinium]; Atropine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Atropine inhibits the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:16263091 PMID:21599003 PMID:23770354 |
|
NCBI chr17:12,584,189...12,628,489
Ensembl chr17:12,584,132...12,628,488
|
|
G |
Slc22a3 |
solute carrier family 22 (organic cation transporter), member 3 |
increases uptake multiple interactions |
ISO |
SLC22A3 protein results in increased uptake of Atropine Atropine inhibits the reaction [SLC22A3 protein results in increased transport of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:16263091 |
|
NCBI chr17:12,419,972...12,507,704
Ensembl chr17:12,418,960...12,507,704
|
|
G |
Slc22a4 |
solute carrier family 22 (organic cation transporter), member 4 |
multiple interactions |
ISO |
Atropine inhibits the reaction [SLC22A4 protein results in increased uptake of Tetraethylammonium] |
CTD |
PMID:21641380 |
|
NCBI chr11:53,983,115...54,030,040
Ensembl chr11:53,983,123...54,028,090
|
|
G |
Slc47a1 |
solute carrier family 47, member 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr11:61,343,400...61,378,842
Ensembl chr11:61,343,401...61,378,345
|
|
G |
Slc47a2 |
solute carrier family 47, member 2 |
multiple interactions |
ISO |
Atropine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr11:61,301,627...61,342,860
Ensembl chr11:61,301,631...61,342,860
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of SOCS3 mRNA] |
CTD |
PMID:22245128 |
|
NCBI chr11:117,966,079...117,970,336
Ensembl chr11:117,966,079...117,970,047
|
|
G |
Spn |
sialophorin |
increases response to substance |
EXP |
SPN protein results in increased susceptibility to Atropine |
CTD |
PMID:18711009 |
|
NCBI chr 7:127,123,637...127,145,552
Ensembl chr 7:127,132,232...127,137,823
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
ISO |
[Atropine co-treated with Obidoxime Chloride co-treated with Diazepam] inhibits the reaction [Dichlorvos results in increased expression of TAT protein] |
CTD |
PMID:7761789 |
|
NCBI chr 8:109,986,078...109,999,804
Ensembl chr 8:109,990,437...109,999,803
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] |
CTD |
PMID:18472332 |
|
NCBI chr 7:25,687,002...25,705,077
Ensembl chr 7:25,687,002...25,705,077
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of TNF mRNA]; [Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of TNF protein] |
CTD |
PMID:22245128 |
|
NCBI chr17:35,199,367...35,202,007
Ensembl chr17:35,199,381...35,202,007
|
|
G |
Trio |
triple functional domain (PTPRF interacting) |
multiple interactions |
ISO |
Atropine inhibits the reaction [Parathion results in increased expression of TRIO protein] |
CTD |
PMID:17390078 |
|
NCBI chr15:27,730,649...28,025,848
Ensembl chr15:27,730,651...28,025,848
|
|
G |
Trp53 |
transformation related protein 53 |
multiple interactions |
ISO |
Atropine inhibits the reaction [Malathion results in increased expression of TP53 protein]; Atropine inhibits the reaction [Parathion results in increased expression of TP53 protein] |
CTD |
PMID:12762645 |
|
NCBI chr11:69,580,348...69,591,873
Ensembl chr11:69,580,359...69,591,873
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
decreases response to substance |
EXP |
TRPA1 gene mutant form results in decreased susceptibility to Atropine |
CTD |
PMID:29627347 |
|
NCBI chr 1:14,872,644...14,918,862
Ensembl chr 1:14,872,648...14,918,862
|
|
G |
Tshb |
thyroid stimulating hormone, beta subunit |
multiple interactions |
ISO |
[pralidoxime co-treated with Atropine] inhibits the reaction [methamidophos results in decreased expression of TSHB protein] |
CTD |
PMID:15891268 |
|
NCBI chr 3:102,777,398...102,789,082
Ensembl chr 3:102,775,465...102,782,718
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
EXP |
[Ketamine co-treated with Atropine] inhibits the reaction [Soman results in increased expression of VCAM1 mRNA] |
CTD |
PMID:22245128 |
|
NCBI chr 3:116,110,020...116,129,688
Ensembl chr 3:116,109,949...116,129,688
|
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Butylscopolammonium Bromide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,584,189...12,628,489
Ensembl chr17:12,584,132...12,628,488
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
affects expression |
ISO |
Cocaine affects the expression of AACS mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:125,475,873...125,517,405
Ensembl chr 5:125,475,814...125,517,410
|
|
G |
Aadac |
arylacetamide deacetylase |
decreases expression |
ISO |
Cocaine results in decreased expression of AADAC mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 3:60,031,788...60,040,157
Ensembl chr 3:60,025,717...60,040,160
|
|
G |
Aanat |
arylalkylamine N-acetyltransferase |
affects response to substance |
EXP |
AANAT protein affects the susceptibility to Cocaine |
CTD |
PMID:12138020 |
|
NCBI chr11:116,591,721...116,597,680
Ensembl chr11:116,586,432...116,597,680
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
increases response to substance |
EXP |
ABAT mRNA results in increased susceptibility to Cocaine |
CTD |
PMID:10850552 |
|
NCBI chr16:8,513,429...8,621,568
Ensembl chr16:8,513,429...8,621,568
|
|
G |
Abca4 |
ATP-binding cassette, sub-family A (ABC1), member 4 |
decreases expression |
ISO |
Cocaine results in decreased expression of ABCA4 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 3:122,043,891...122,180,070
Ensembl chr 3:122,044,443...122,180,123
|
|
G |
Abca5 |
ATP-binding cassette, sub-family A (ABC1), member 5 |
multiple interactions |
EXP |
HDAC5 affects the reaction [Cocaine affects the expression of ABCA5 mRNA] |
CTD |
PMID:17988634 |
|
NCBI chr11:110,269,369...110,337,723
Ensembl chr11:110,269,369...110,337,716
|
|
G |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
affects expression |
ISO |
Cocaine affects the expression of ABCC3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:94,343,295...94,393,017
Ensembl chr11:94,343,295...94,392,997
|
|
G |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
affects expression |
ISO |
Cocaine affects the expression of ABCC5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr16:20,331,303...20,426,428
Ensembl chr16:20,331,303...20,426,394
|
|
G |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
affects expression |
ISO |
Cocaine affects the expression of ABCC9 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:142,587,862...142,702,766
Ensembl chr 6:142,587,862...142,702,315
|
|
G |
Abcd4 |
ATP-binding cassette, sub-family D (ALD), member 4 |
affects expression |
ISO |
Cocaine affects the expression of ABCD4 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:84,601,869...84,617,485
Ensembl chr12:84,601,464...84,617,413
|
|
G |
Abhd1 |
abhydrolase domain containing 1 |
decreases expression |
EXP |
Cocaine results in decreased expression of ABHD1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 5:30,950,066...30,955,095
Ensembl chr 5:30,950,066...30,955,091
|
|
G |
Abhd14a |
abhydrolase domain containing 14A |
affects expression |
ISO |
Cocaine affects the expression of ABHD14A mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:106,440,051...106,451,203
Ensembl chr 9:106,440,051...106,447,678
|
|
G |
Abhd17a |
abhydrolase domain containing 17A |
affects expression |
ISO |
Cocaine affects the expression of ABHD17A mRNA |
CTD |
PMID:20187946 |
|
NCBI chr10:80,583,649...80,590,341
Ensembl chr10:80,583,654...80,590,341
|
|
G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
affects expression |
EXP |
Cocaine affects the expression of ABL1 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 2:31,688,244...31,807,093
Ensembl chr 2:31,688,376...31,804,227
|
|
G |
Acaa1b |
acetyl-Coenzyme A acyltransferase 1B |
increases expression |
EXP |
Cocaine results in increased expression of ACAA1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 9:119,148,043...119,157,093
Ensembl chr 9:119,148,023...119,157,093
|
|
G |
Acan |
aggrecan |
affects expression |
ISO |
Cocaine affects the expression of ACAN mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:79,053,226...79,115,099
Ensembl chr 7:79,053,483...79,115,099
|
|
G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
multiple interactions |
ISO |
ACE inhibits the reaction [Cocaine affects the abundance of Dinoprostone]; ACE inhibits the reaction [Cocaine affects the abundance of Epoprostenol] |
CTD |
PMID:14738173 |
|
NCBI chr11:105,967,948...105,989,964
Ensembl chr11:105,967,945...105,989,964
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
affects expression |
EXP |
Cocaine affects the expression of ACIN1 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr14:54,642,161...54,686,965
Ensembl chr14:54,642,161...54,686,931
|
|
G |
Ackr2 |
atypical chemokine receptor 2 |
affects expression |
ISO |
Cocaine affects the expression of ACKR2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:121,898,355...121,911,075
Ensembl chr 9:121,898,355...121,911,074
|
|
G |
Aco2 |
aconitase 2, mitochondrial |
increases expression |
EXP |
Cocaine results in increased expression of ACO2 protein modified form |
CTD |
PMID:24096156 |
|
NCBI chr15:81,872,463...81,915,137
Ensembl chr15:81,872,309...81,915,133
|
|
G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
affects expression |
ISO |
Cocaine affects the expression of ACSL5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:55,251,861...55,296,628
Ensembl chr19:55,251,938...55,297,720
|
|
G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of ACSS1 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 2:150,618,111...150,668,240
Ensembl chr 2:150,618,105...150,668,500
|
|
G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
decreases expression |
ISO |
Cocaine results in decreased expression of ACTG2 mRNA |
CTD |
PMID:20948987 |
|
NCBI chr 6:83,512,909...83,536,251
Ensembl chr 6:83,512,905...83,536,265
|
|
G |
Actn2 |
actinin alpha 2 |
increases expression |
ISO |
Cocaine results in increased expression of ACTN2 mRNA |
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr13:12,269,426...12,340,732
Ensembl chr13:12,269,426...12,340,760
|
|
G |
Acvr1c |
activin A receptor, type IC |
increases expression |
ISO |
Cocaine results in increased expression of ACVR1C mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:58,267,453...58,357,896
Ensembl chr 2:58,267,453...58,357,895
|
|
G |
Acy3 |
aspartoacylase (aminoacylase) 3 |
affects expression |
ISO |
Cocaine affects the expression of ACY3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:3,986,570...3,990,007
Ensembl chr19:3,986,570...3,990,007
|
|
G |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
decreases expression |
ISO |
Cocaine results in decreased expression of ADAM19 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:46,054,502...46,147,347
Ensembl chr11:46,055,992...46,147,343
|
|
G |
Adam1a |
a disintegrin and metallopeptidase domain 1a |
multiple interactions |
EXP |
HDAC5 affects the reaction [Cocaine affects the expression of ADAM1A mRNA] |
CTD |
PMID:17988634 |
|
NCBI chr 5:121,518,604...121,521,695
Ensembl chr 5:121,518,576...121,545,482
|
|
G |
Adamts19 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19 |
decreases expression |
ISO |
Cocaine results in decreased expression of ADAMTS19 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr18:58,835,992...59,053,682
Ensembl chr18:58,836,667...59,054,060
|
|
G |
Adat2 |
adenosine deaminase, tRNA-specific 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of ADAT2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr10:13,552,907...13,563,376
Ensembl chr10:13,552,894...13,563,376
|
|
G |
Adcy2 |
adenylate cyclase 2 |
affects expression |
ISO |
Cocaine affects the expression of ADCY2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr13:68,620,043...68,999,600
Ensembl chr13:68,620,043...68,999,541
|
|
G |
Adcy8 |
adenylate cyclase 8 |
affects expression |
ISO |
Cocaine affects the expression of ADCY8 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:64,699,035...64,922,296
Ensembl chr15:64,697,084...64,922,296
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
multiple interactions increases expression |
EXP |
ADCYAP1 protein modified form affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; ADCYAP1 protein modified form affects the reaction [Cocaine results in increased expression of BAX protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA] |
CTD |
PMID:29673861 |
|
NCBI chr17:93,198,245...93,206,541
Ensembl chr17:93,199,017...93,206,537
|
|
G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
multiple interactions increases expression |
EXP |
alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA] |
CTD |
PMID:29673861 |
|
NCBI chr 6:55,451,501...55,501,455
Ensembl chr 6:55,451,978...55,501,451
|
|
G |
Adgra1 |
adhesion G protein-coupled receptor A1 |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in increased expression of ADGRA1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 7:139,834,097...139,878,088
Ensembl chr 7:139,834,174...139,878,088
|
|
G |
Adgre1 |
adhesion G protein-coupled receptor E1 |
affects expression |
ISO |
Cocaine affects the expression of ADGRE1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr17:57,358,581...57,483,529
Ensembl chr17:57,358,691...57,483,527
|
|
G |
Adgrf1 |
adhesion G protein-coupled receptor F1 |
decreases expression |
ISO |
Cocaine results in decreased expression of ADGRF1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr17:43,270,283...43,325,876
Ensembl chr17:43,270,329...43,324,737
|
|
G |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
affects expression |
ISO |
Cocaine affects the expression of ADGRL1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 8:83,900,098...83,941,954
Ensembl chr 8:83,900,105...83,941,954
|
|
G |
Adgrl3 |
adhesion G protein-coupled receptor L3 |
affects expression |
ISO |
Cocaine affects the expression of ADGRL3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:81,019,085...81,827,825
Ensembl chr 5:81,020,138...81,825,133
|
|
G |
Adora1 |
adenosine A1 receptor |
affects expression affects response to substance |
ISO EXP |
Cocaine affects the expression of ADORA1 mRNA; Cocaine affects the expression of ADORA1 protein ADORA1 affects the susceptibility to Cocaine |
CTD |
PMID:12358776 PMID:19092996 |
|
NCBI chr 1:134,199,215...134,235,457
Ensembl chr 1:134,199,223...134,235,431
|
|
G |
Adora2a |
adenosine A2a receptor |
increases response to substance |
EXP |
ADORA2A results in increased susceptibility to Cocaine |
CTD |
PMID:16123743 |
|
NCBI chr10:75,316,877...75,334,792
Ensembl chr10:75,316,877...75,334,784
|
|
G |
Adora2b |
adenosine A2b receptor |
affects expression |
ISO |
Cocaine affects the expression of ADORA2B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:62,248,984...62,266,452
Ensembl chr11:62,248,984...62,266,453
|
|
G |
Adra1b |
adrenergic receptor, alpha 1b |
increases response to substance |
EXP |
ADRA1B gene results in increased susceptibility to Cocaine |
CTD |
PMID:14556232 |
|
NCBI chr11:43,774,605...43,901,250
Ensembl chr11:43,774,606...43,901,210
|
|
G |
Adrb1 |
adrenergic receptor, beta 1 |
multiple interactions affects expression |
ISO |
Betaxolol affects the reaction [Cocaine affects the expression of ADRB1 protein]; Betaxolol inhibits the reaction [Cocaine affects the expression of ADRB1 protein] |
CTD |
PMID:17513029 PMID:18596687 |
|
NCBI chr19:56,722,117...56,725,150
Ensembl chr19:56,722,199...56,733,113
|
|
G |
Aff4 |
AF4/FMR2 family, member 4 |
increases expression |
ISO |
Cocaine results in increased expression of AFF4 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:53,350,640...53,421,830
Ensembl chr11:53,350,833...53,421,830
|
|
G |
Afmid |
arylformamidase |
increases expression |
ISO |
Cocaine results in increased expression of AFMID mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:117,825,503...117,839,908
Ensembl chr11:117,825,924...117,839,908
|
|
G |
Afp |
alpha fetoprotein |
increases expression |
ISO |
Cocaine results in increased expression of AFP mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 5:90,490,714...90,508,907
Ensembl chr 5:90,490,737...90,508,907
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
affects expression |
ISO |
Cocaine affects the expression of AGAP2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr10:127,075,269...127,093,170
Ensembl chr10:127,075,284...127,093,169
|
|
G |
Ago2 |
argonaute RISC catalytic subunit 2 |
multiple interactions affects response to substance |
EXP |
AGO2 protein affects the reaction [Cocaine results in increased expression of MIR130A mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR136 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR137 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR138-1 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR148B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR154 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR181A1 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR186 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR301B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR324 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR337 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR369 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR376A mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR376C mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR380 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR384 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR467B mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR488 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR500 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR544 mRNA]; AGO2 protein affects the reaction [Cocaine results in increased expression of MIR665 mRNA] AGO2 protein affects the susceptibility to Cocaine |
CTD |
PMID:20643829 |
|
NCBI chr15:73,101,625...73,184,947
Ensembl chr15:73,095,844...73,184,935
|
|
G |
Aif1l |
allograft inflammatory factor 1-like |
decreases expression |
ISO |
Cocaine results in decreased expression of AIF1L mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 2:31,950,303...31,973,442
Ensembl chr 2:31,950,139...31,973,442
|
|
G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
affects expression increases expression |
EXP ISO |
Cocaine affects the expression of AIFM1 mRNA Cocaine results in increased expression of AIFM1 mRNA |
CTD |
PMID:15681117 PMID:18000554 |
|
NCBI chr X:48,474,944...48,513,563
Ensembl chr X:48,474,944...48,513,563
|
|
G |
Aifm2 |
apoptosis-inducing factor, mitochondrion-associated 2 |
affects expression |
EXP |
Cocaine affects the expression of AIFM2 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr10:61,715,263...61,739,260
Ensembl chr10:61,715,263...61,739,260
|
|
G |
Ak1 |
adenylate kinase 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of AK1 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 2:32,621,758...32,635,058
Ensembl chr 2:32,621,758...32,635,058
|
|
G |
Ak3 |
adenylate kinase 3 |
affects expression |
ISO |
Cocaine affects the expression of AK3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:28,995,053...29,048,080
Ensembl chr19:29,020,833...29,047,961
|
|
G |
Akr1d1 |
aldo-keto reductase family 1, member D1 |
affects expression |
ISO |
Cocaine affects the expression of AKR1D1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:37,529,978...37,574,921
Ensembl chr 6:37,530,173...37,568,815
|
|
G |
Akr1e1 |
aldo-keto reductase family 1, member E1 |
affects expression |
ISO |
Cocaine affects the expression of AKR1E1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr13:4,591,123...4,609,164
Ensembl chr13:4,590,750...4,609,174
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
affects expression multiple interactions increases phosphorylation |
ISO EXP |
Cocaine affects the expression of AKT1 mRNA [Cocaine co-treated with cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester] results in increased phosphorylation of AKT1 protein Cocaine results in increased phosphorylation of AKT1 protein Cocaine affects the reaction [ILK protein affects the phosphorylation of AKT1 protein] |
CTD |
PMID:18702665 PMID:20187946 PMID:25933444 |
|
NCBI chr12:112,653,821...112,674,884
Ensembl chr12:112,653,821...112,674,884
|
|
G |
Alcam |
activated leukocyte cell adhesion molecule |
increases expression |
ISO |
Cocaine results in increased expression of ALCAM mRNA |
CTD |
PMID:17898221 |
|
NCBI chr16:52,248,996...52,453,081
Ensembl chr16:52,248,996...52,454,074
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
multiple interactions |
ISO |
[[CVT-10216 results in decreased activity of ALDH2 protein] which results in increased abundance of Tetrahydropapaveroline] inhibits the reaction [Cocaine results in increased abundance of and results in increased secretion of Dopamine]; [ALDH2 protein affects the abundance of Tetrahydropapaveroline] which affects the susceptibility to Cocaine; ALDH2 protein affects the reaction [Cocaine results in increased abundance of Dopamine] |
CTD |
PMID:20729865 |
|
NCBI chr 5:121,566,027...121,593,824
Ensembl chr 5:121,566,027...121,593,824
|
|
G |
Ambra1 |
autophagy/beclin 1 regulator 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of AMBRA1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:91,730,138...91,918,849
Ensembl chr 2:91,730,134...91,918,849
|
|
G |
Amh |
anti-Mullerian hormone |
increases expression |
ISO |
Cocaine results in increased expression of AMH mRNA |
CTD |
PMID:17898221 |
|
NCBI chr10:80,805,240...80,807,679
Ensembl chr10:80,805,243...80,807,648
|
|
G |
Amigo1 |
adhesion molecule with Ig like domain 1 |
affects expression |
ISO |
Cocaine affects the expression of AMIGO1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 3:108,186,289...108,192,286
Ensembl chr 3:108,186,335...108,192,286
|
|
G |
Amigo3 |
adhesion molecule with Ig like domain 3 |
affects expression |
ISO |
Cocaine affects the expression of AMIGO3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:108,053,159...108,055,701
Ensembl chr 9:108,053,159...108,055,701
|
|
G |
Amn1 |
antagonist of mitotic exit network 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of AMN1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 6:149,157,261...149,188,712
Ensembl chr 6:149,157,147...149,188,712
|
|
G |
Ankrd54 |
ankyrin repeat domain 54 |
affects expression |
ISO |
Cocaine affects the expression of ANKRD54 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:79,053,094...79,062,927
Ensembl chr15:79,053,094...79,062,893
|
|
G |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
decreases expression |
ISO |
Cocaine results in decreased expression of ANKS1B mRNA |
CTD |
PMID:17898221 |
|
NCBI chr10:89,872,915...90,973,300
Ensembl chr10:89,873,509...90,973,300
|
|
G |
Anxa7 |
annexin A7 |
affects expression |
ISO |
Cocaine affects the expression of ANXA7 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr14:20,455,261...20,480,133
Ensembl chr14:20,455,260...20,480,133
|
|
G |
Ap1ar |
adaptor-related protein complex 1 associated regulatory protein |
increases expression |
ISO |
Cocaine results in increased expression of AP1AR mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 3:127,807,007...127,837,523
Ensembl chr 3:127,807,007...127,837,523
|
|
G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
affects expression |
ISO |
Cocaine affects the expression of AP2B1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:83,298,719...83,405,035
Ensembl chr11:83,299,024...83,405,035
|
|
G |
Ap2m1 |
adaptor-related protein complex 2, mu 1 subunit |
increases expression |
ISO |
Cocaine results in increased expression of AP2M1 protein |
CTD |
PMID:25100957 |
|
NCBI chr16:20,535,480...20,544,909
Ensembl chr16:20,535,478...20,544,909
|
|
G |
Ap2s1 |
adaptor-related protein complex 2, sigma 1 subunit |
decreases expression |
ISO |
Cocaine results in decreased expression of AP2S1 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 7:16,738,444...16,749,290
Ensembl chr 7:16,738,410...16,749,294
|
|
G |
Ap5m1 |
adaptor-related protein complex 5, mu 1 subunit |
affects expression |
ISO |
Cocaine affects the expression of AP5M1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr14:49,066,408...49,094,114
Ensembl chr14:49,066,097...49,094,234
|
|
G |
Apcs |
serum amyloid P-component |
increases expression |
ISO |
Cocaine results in increased expression of APCS protein |
CTD |
PMID:12714198 |
|
NCBI chr 1:172,893,961...172,895,054
Ensembl chr 1:172,893,961...172,895,041
|
|
G |
Aph1a |
aph1 homolog A, gamma secretase subunit |
affects expression |
ISO |
Cocaine affects the expression of APH1A mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 3:95,893,921...95,898,592
Ensembl chr 3:95,893,969...95,898,288
|
|
G |
Aplnr |
apelin receptor |
increases expression |
ISO |
Cocaine results in increased expression of APLNR mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:85,136,360...85,139,923
Ensembl chr 2:85,136,225...85,139,923
|
|
G |
Apol11a |
apolipoprotein L 11a |
decreases expression |
ISO |
Cocaine results in decreased expression of APOL11A mRNA |
CTD |
PMID:27899881 |
|
NCBI chr15:77,508,129...77,517,874
Ensembl chr15:77,508,271...77,518,051
|
|
G |
Apol8 |
apolipoprotein L 8 |
increases expression |
ISO |
Cocaine results in increased expression of APOL2 mRNA |
CTD |
PMID:17205118 |
|
NCBI chr15:77,745,109...77,757,062
Ensembl chr15:77,747,798...77,757,003
|
|
G |
Apold1 |
apolipoprotein L domain containing 1 |
affects expression |
ISO |
Cocaine affects the expression of APOLD1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:134,982,001...134,986,836
Ensembl chr 6:134,981,718...134,986,836
|
|
G |
Apoo |
apolipoprotein O |
increases expression |
ISO |
Cocaine results in increased expression of APOO protein |
CTD |
PMID:25100957 |
|
NCBI chr X:94,367,010...94,417,093
Ensembl chr X:94,367,117...94,417,093
|
|
G |
App |
amyloid beta (A4) precursor protein |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of APP mRNA Cocaine results in increased expression of APP mRNA |
CTD |
PMID:15009677 PMID:16710320 PMID:17898221 |
|
NCBI chr16:84,952,666...85,175,255
Ensembl chr16:84,949,685...85,173,766
|
|
G |
Appl1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
increases expression |
ISO |
Cocaine results in increased expression of APPL1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr14:26,918,986...26,970,611
Ensembl chr14:26,918,988...26,971,232
|
|
G |
Arc |
activity regulated cytoskeletal-associated protein |
affects expression increases expression multiple interactions |
ISO |
Cocaine affects the expression of ARC mRNA Cocaine results in increased expression of ARC mRNA; Cocaine results in increased expression of ARC protein Reserpine inhibits the reaction [Cocaine results in increased expression of ARC mRNA] |
CTD |
PMID:7722525 PMID:12117546 PMID:15254092 PMID:17851536 PMID:18311559 PMID:18361437 PMID:20187946 PMID:24810662 |
|
NCBI chr15:74,669,081...74,672,570
Ensembl chr15:74,669,083...74,672,570
|
|
G |
Arf4 |
ADP-ribosylation factor 4 |
decreases expression |
ISO |
Cocaine results in decreased expression of ARF4 protein |
CTD |
PMID:25100957 |
|
NCBI chr14:26,638,134...26,656,842
Ensembl chr14:26,638,074...26,665,084
|
|
G |
Arhgap1 |
Rho GTPase activating protein 1 |
increases expression |
ISO |
Cocaine results in increased expression of ARHGAP1 protein |
CTD |
PMID:25100957 |
|
NCBI chr 2:91,650,118...91,672,325
Ensembl chr 2:91,649,860...91,672,326
|
|
G |
Arhgap29 |
Rho GTPase activating protein 29 |
decreases expression |
ISO |
Cocaine results in decreased expression of ARHGAP29 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 3:121,953,113...122,016,677
Ensembl chr 3:121,952,541...122,016,753
|
|
G |
Arhgap30 |
Rho GTPase activating protein 30 |
increases expression |
ISO |
Cocaine results in increased expression of ARHGAP30 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:171,388,960...171,410,240
Ensembl chr 1:171,388,954...171,410,298
|
|
G |
Arhgap44 |
Rho GTPase activating protein 44 |
decreases expression |
ISO |
Cocaine results in decreased expression of ARHGAP44 protein |
CTD |
PMID:25100957 |
|
NCBI chr11:65,002,039...65,162,972
Ensembl chr11:65,002,039...65,162,961
|
|
G |
Arhgap5 |
Rho GTPase activating protein 5 |
increases expression |
ISO |
Cocaine results in increased expression of ARHGAP5 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr12:52,503,763...52,571,978
Ensembl chr12:52,503,972...52,571,975
|
|
G |
Arhgap9 |
Rho GTPase activating protein 9 |
decreases expression |
ISO |
Cocaine results in decreased expression of ARHGAP9 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr10:127,321,913...127,329,947
Ensembl chr10:127,321,964...127,329,943
|
|
G |
Arhgef1 |
Rho guanine nucleotide exchange factor (GEF) 1 |
affects expression |
ISO |
Cocaine affects the expression of ARHGEF1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:24,902,986...24,926,594
Ensembl chr 7:24,902,912...24,926,594
|
|
G |
Arhgef7 |
Rho guanine nucleotide exchange factor (GEF7) |
affects expression |
ISO |
Cocaine affects the expression of ARHGEF7 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 8:11,728,001...11,835,219
Ensembl chr 8:11,727,721...11,835,219
|
|
G |
Armcx6 |
armadillo repeat containing, X-linked 6 |
affects expression |
ISO |
Cocaine affects the expression of ARMCX6 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr X:134,748,455...134,756,666
Ensembl chr X:134,748,461...134,751,417
|
|
G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
decreases expression |
EXP |
Cocaine results in decreased expression of ARNTL mRNA |
CTD |
PMID:15994025 |
|
NCBI chr 7:113,178,471...113,314,126
Ensembl chr 7:113,207,465...113,314,126
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
increases expression |
ISO |
Cocaine results in increased expression of ARPC1A protein |
CTD |
PMID:25100957 |
|
NCBI chr 5:145,083,869...145,108,756
Ensembl chr 5:145,083,830...145,108,761
|
|
G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
multiple interactions |
ISO |
Cocaine inhibits the reaction [SK&F 81297 results in increased phosphorylation of ARPP19 protein] |
CTD |
PMID:11268215 |
|
NCBI chr 9:75,037,614...75,060,313
Ensembl chr 9:75,037,614...75,060,313
|
|
G |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
multiple interactions |
ISO |
Cocaine inhibits the reaction [SK&F 81297 results in increased phosphorylation of ARPP21 protein] |
CTD |
PMID:11268215 |
|
NCBI chr 9:112,065,091...112,236,288
Ensembl chr 9:112,065,091...112,235,938
|
|
G |
Art5 |
ADP-ribosyltransferase 5 |
increases expression |
ISO |
Cocaine results in increased expression of ART5 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 7:102,096,879...102,100,291
Ensembl chr 7:102,096,879...102,109,489
|
|
G |
As3mt |
arsenite methyltransferase |
affects expression |
ISO |
Cocaine affects the expression of AS3MT mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:46,707,157...46,741,099
Ensembl chr19:46,707,458...46,741,099
|
|
G |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
decreases expression |
ISO |
Cocaine results in decreased expression of ASAP1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr15:64,086,840...64,382,941
Ensembl chr15:64,086,857...64,382,919
|
|
G |
Atad1 |
ATPase family, AAA domain containing 1 |
increases expression |
ISO |
Cocaine results in increased expression of ATAD1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr19:32,672,558...32,739,787
Ensembl chr19:32,671,638...32,739,786
|
|
G |
Atad5 |
ATPase family, AAA domain containing 5 |
decreases expression |
ISO |
Cocaine results in decreased expression of ATAD5 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:80,089,379...80,135,797
Ensembl chr11:80,089,400...80,135,794
|
|
G |
Ate1 |
arginyltransferase 1 |
increases expression |
ISO |
Cocaine results in increased expression of ATE1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 7:130,391,493...130,520,619
Ensembl chr 7:130,391,493...130,520,369
|
|
G |
Atf3 |
activating transcription factor 3 |
increases expression decreases expression |
ISO |
Cocaine results in increased expression of ATF3 mRNA Cocaine results in decreased expression of ATF3 mRNA |
CTD |
PMID:23644055 PMID:27899881 |
|
NCBI chr 1:191,170,296...191,183,333
Ensembl chr 1:191,170,296...191,218,039
|
|
G |
Atf4 |
activating transcription factor 4 |
increases expression |
ISO |
Cocaine results in increased expression of ATF4; Cocaine results in increased expression of ATF4 mRNA |
CTD |
PMID:18593214 PMID:23644055 |
|
NCBI chr15:80,255,184...80,257,545
Ensembl chr15:80,255,184...80,257,541
|
|
G |
Atf6 |
activating transcription factor 6 |
affects expression |
ISO |
Cocaine affects the expression of ATF6 mRNA |
CTD |
PMID:23644055 |
|
NCBI chr 1:170,704,457...170,868,585
Ensembl chr 1:170,704,674...170,867,771
|
|
G |
Atf7 |
activating transcription factor 7 |
affects expression |
EXP |
Cocaine affects the expression of ATF7 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr15:102,525,946...102,625,464
Ensembl chr15:102,525,946...102,625,464
|
|
G |
Atg2b |
autophagy related 2B |
affects expression |
ISO |
Cocaine affects the expression of ATG2B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:105,613,539...105,685,297
Ensembl chr12:105,616,136...105,685,211
|
|
G |
Atg4b |
autophagy related 4B, cysteine peptidase |
affects expression |
ISO |
Cocaine affects the expression of ATG4B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 1:93,754,905...93,789,606
Ensembl chr 1:93,751,500...93,790,610
|
|
G |
Atm |
ataxia telangiectasia mutated |
multiple interactions increases expression |
EXP |
EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA] |
CTD |
PMID:20056891 |
|
NCBI chr 9:53,437,122...53,536,828
Ensembl chr 9:53,439,149...53,536,740
|
|
G |
Atp10a |
ATPase, class V, type 10A |
decreases expression |
ISO |
Cocaine results in decreased expression of ATP10A mRNA |
CTD |
PMID:17898221 PMID:27899881 |
|
NCBI chr 7:58,656,142...58,830,244
Ensembl chr 7:58,656,166...58,829,420
|
|
G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
affects expression |
EXP |
Cocaine affects the expression of ATP1A1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 3:101,576,219...101,604,707
Ensembl chr 3:101,576,219...101,604,684
|
|
G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
increases expression affects expression |
ISO |
Cocaine results in increased expression of ATP1A3 mRNA Cocaine affects the expression of ATP1A3 mRNA |
CTD |
PMID:16076954 PMID:20187946 |
|
NCBI chr 7:24,978,167...25,006,077
Ensembl chr 7:24,978,167...25,005,958
|
|
G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
increases expression |
ISO |
Cocaine results in increased expression of ATP1B2 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr11:69,599,728...69,605,978
Ensembl chr11:69,599,736...69,605,942
|
|
G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of ATP1B3 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP1B3 mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr 9:96,332,655...96,364,431
Ensembl chr 9:96,332,655...96,364,442
|
|
G |
Atp5a1 |
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 |
affects expression |
ISO |
Cocaine affects the expression of ATP5F1A protein |
CTD |
PMID:19393250 |
|
NCBI chr18:77,773,768...77,782,869
Ensembl chr18:77,773,729...77,782,869
|
|
G |
Atp5b |
ATP synthase, H+ transporting mitochondrial F1 complex, beta subunit |
decreases expression |
ISO |
Cocaine results in decreased expression of ATP5F1B protein |
CTD |
PMID:17075605 |
|
NCBI chr10:128,083,307...128,090,388
Ensembl chr10:128,083,273...128,090,391
|
|
G |
Atp5e |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
affects expression |
ISO |
Cocaine affects the expression of ATP5F1E mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:174,461,075...174,464,101
Ensembl chr 2:174,461,072...174,464,105
|
|
G |
Atp5g3 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C3 (subunit 9) |
decreases expression affects expression |
ISO |
Cocaine results in decreased expression of ATP5MC3 mRNA Cocaine affects the expression of ATP5MC3 mRNA |
CTD |
PMID:12629581 PMID:20187946 |
|
NCBI chr 2:73,908,447...73,912,464
Ensembl chr 2:73,908,447...73,911,326
|
|
G |
Atp5h |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit D |
affects expression |
ISO |
Cocaine affects the expression of ATP5H mRNA |
CTD |
PMID:12358776 |
|
NCBI chr11:115,415,691...115,419,919
Ensembl chr11:115,415,689...115,419,962
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
affects expression |
ISO |
Cocaine affects the expression of ATP5PB mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 3:105,942,698...105,959,263
Ensembl chr 3:105,942,698...105,960,099
|
|
G |
Atp6v1d |
ATPase, H+ transporting, lysosomal V1 subunit D |
affects expression |
ISO |
Cocaine affects the expression of ATP6V1D mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:78,842,982...78,862,008
Ensembl chr12:78,840,725...78,861,638
|
|
G |
Atp8b2 |
ATPase, class I, type 8B, member 2 |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of ATP8B2 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP8B2 mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr 3:89,939,481...89,963,338
Ensembl chr 3:89,939,481...89,963,508
|
|
G |
Atp9b |
ATPase, class II, type 9B |
affects response to substance |
ISO |
ATP9B gene SNP affects the susceptibility to Cocaine |
CTD |
PMID:18438686 |
|
NCBI chr18:80,734,141...80,934,081
Ensembl chr18:80,734,141...80,934,060
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 4:115,784,828...115,811,923
Ensembl chr 4:115,784,812...115,822,655
|
|
G |
Atrx |
ATRX, chromatin remodeler |
increases expression |
ISO |
Cocaine results in increased expression of ATRX mRNA |
CTD |
PMID:17898221 |
|
NCBI chr X:105,797,615...105,929,372
Ensembl chr X:105,797,615...105,929,403
|
|
G |
Atxn1 |
ataxin 1 |
affects expression |
ISO |
Cocaine affects the expression of ATXN1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr13:45,549,755...45,964,991
Ensembl chr13:45,549,755...45,965,008
|
|
G |
Atxn3 |
ataxin 3 |
decreases expression |
ISO |
Cocaine results in decreased expression of ATXN3 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr12:101,918,901...101,959,121
Ensembl chr12:101,918,901...101,958,246
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc |
decreases expression |
ISO |
Cocaine results in decreased expression of AZGP1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 5:137,981,521...137,990,233
Ensembl chr 5:137,981,520...137,990,233
|
|
G |
Baalc |
brain and acute leukemia, cytoplasmic |
decreases expression |
EXP |
Cocaine results in decreased expression of BAALC mRNA |
CTD |
PMID:18355967 |
|
NCBI chr15:38,933,909...38,951,264
Ensembl chr15:38,933,144...38,952,912
|
|
G |
Bach1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
increases expression |
ISO |
Cocaine results in increased expression of BACH1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr16:87,698,954...87,733,346
Ensembl chr16:87,698,945...87,733,346
|
|
G |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
affects expression |
EXP |
Cocaine affects the expression of BACH2 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 4:32,238,413...32,586,109
Ensembl chr 4:32,238,804...32,586,108
|
|
G |
Bad |
BCL2-associated agonist of cell death |
affects expression |
EXP |
Cocaine affects the expression of BAD mRNA |
CTD |
PMID:15681117 |
|
NCBI chr19:6,941,861...6,951,905
Ensembl chr19:6,941,861...6,951,899
|
|
G |
Bag1 |
BCL2-associated athanogene 1 |
affects expression |
EXP |
Cocaine affects the expression of BAG1 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 4:40,936,398...40,948,294
Ensembl chr 4:40,936,398...40,948,294
|
|
G |
Bag3 |
BCL2-associated athanogene 3 |
affects expression increases expression |
EXP ISO |
Cocaine affects the expression of BAG3 mRNA Cocaine results in increased expression of BAG3 mRNA |
CTD |
PMID:15681117 PMID:27899881 |
|
NCBI chr 7:128,523,583...128,546,981
Ensembl chr 7:128,523,616...128,546,981
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
affects expression |
ISO |
Cocaine affects the expression of BAMBI mRNA |
CTD |
PMID:20187946 |
|
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
|
|
G |
Basp1 |
brain abundant, membrane attached signal protein 1 |
affects expression |
ISO |
Cocaine affects the expression of BASP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:25,363,277...25,413,764
Ensembl chr15:25,363,277...25,413,764
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions increases activity affects expression |
ISO EXP |
Cocaine results in increased expression of BAX mRNA ADCYAP1 protein modified form affects the reaction [Cocaine results in increased expression of BAX protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [Cocaine results in increased expression of BAX protein]; IL6 protein affects the reaction [Cocaine results in increased expression of BAX protein]; TNF protein affects the reaction [Cocaine results in increased expression of BAX protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of BAX protein]] Cocaine results in increased activity of BAX protein Cocaine affects the expression of BAX mRNA |
CTD |
PMID:11392460 PMID:15681117 PMID:15685203 PMID:17084983 PMID:17635674 PMID:18974856 PMID:20948987 PMID:29673861 PMID:30393195 |
|
NCBI chr 7:45,461,695...45,466,903
Ensembl chr 7:45,461,697...45,466,898
|
|
G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
multiple interactions increases expression |
EXP |
[SMARCA5 protein co-treated with BAZ1B protein] results in increased susceptibility to Cocaine; Cocaine promotes the reaction [BAZ1B protein binds to SPHKAP gene]; Cocaine results in increased expression of and affects the activity of BAZ1B protein Cocaine results in increased expression of BAZ1B mRNA |
CTD |
PMID:27053203 |
|
NCBI chr 5:135,187,323...135,246,131
Ensembl chr 5:135,187,264...135,246,129
|
|
G |
Baz2b |
bromodomain adjacent to zinc finger domain, 2B |
increases expression |
ISO |
Cocaine results in increased expression of BAZ2B mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:59,899,363...60,209,913
Ensembl chr 2:59,899,363...60,209,839
|
|
G |
Bcap31 |
B cell receptor associated protein 31 |
affects expression |
ISO |
Cocaine affects the expression of BCAP31 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr X:73,686,178...73,717,815
Ensembl chr X:73,686,178...73,716,175
|
|
G |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
affects expression |
ISO |
Cocaine affects the expression of BCAT1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:144,993,835...145,076,157
Ensembl chr 6:144,993,835...145,076,184
|
|
G |
Bche |
butyrylcholinesterase |
affects metabolic processing multiple interactions increases hydrolysis increases metabolic processing decreases response to substance affects hydrolysis decreases metabolic processing affects degradation |
ISO EXP |
BCHE protein affects the metabolism of Cocaine [BCHE protein mutant form results in increased metabolism of Cocaine] which results in increased chemical synthesis of Benzoic Acid; [BCHE protein mutant form results in increased metabolism of Cocaine] which results in increased chemical synthesis of ecgonine methyl ester [BCHE protein mutant form results in increased hydrolysis of Cocaine] which results in increased abundance of Benzoic Acid; [BCHE protein mutant form results in increased hydrolysis of Cocaine] which results in increased abundance of ecgonine methyl ester BCHE protein mutant form results in increased metabolism of Cocaine; BCHE protein results in increased metabolism of Cocaine BCHE protein mutant form results in decreased susceptibility to Cocaine BCHE protein modified form results in increased hydrolysis of Cocaine; BCHE protein mutant form results in increased hydrolysis of Cocaine BCHE protein affects the hydrolysis of Cocaine BCHE protein mutant form results in decreased metabolism of Cocaine BCHE protein mutant form affects the degradation of Cocaine |
CTD |
PMID:572161 PMID:16275916 PMID:17989928 PMID:18514178 PMID:18514640 PMID:19067679 PMID:20060817 PMID:20219449 PMID:20971807 PMID:22917637 PMID:22960160 PMID:24582612 PMID:25814464 PMID:27154495 PMID:30080993 |
|
NCBI chr 3:73,635,805...73,708,436
Ensembl chr 3:73,635,808...73,708,415
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
affects expression multiple interactions decreases expression increases phosphorylation increases expression |
EXP ISO |
Cocaine affects the expression of BCL2 mRNA IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; PRKCD protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; rottlerin inhibits the reaction [Cocaine results in decreased expression of BCL2 protein]; TNF protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2 protein]] Cocaine results in increased phosphorylation of BCL2 protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; 7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein] Cocaine results in decreased expression of BCL2 mRNA; Cocaine results in decreased expression of BCL2 protein Cocaine results in increased expression of BCL2 protein |
CTD |
PMID:11392460 PMID:15365088 PMID:15681117 PMID:15685203 PMID:17084983 PMID:18974856 PMID:19183502 PMID:19879923 PMID:29673861 PMID:30393195 |
|
NCBI chr 1:106,538,176...106,714,290
Ensembl chr 1:106,538,178...106,714,274
|
|
G |
Bcl2l1 |
BCL2-like 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
Cocaine results in increased expression of BCL2L1 mRNA; Cocaine results in increased expression of BCL2L1 mRNA alternative form IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; PRKCD protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; rottlerin inhibits the reaction [Cocaine results in decreased expression of BCL2L1 protein]; TNF protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein]] |
CTD |
PMID:16076954 PMID:29673861 PMID:30393195 |
|
NCBI chr 2:152,758,732...152,833,803
Ensembl chr 2:152,780,668...152,831,728
|
|
G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
increases expression |
ISO |
Cocaine results in increased expression of BCL2L11 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr 2:128,126,038...128,162,547
Ensembl chr 2:128,126,038...128,162,547
|
|
G |
Bdnf |
brain derived neurotrophic factor |
decreases response to substance increases expression decreases activity affects expression multiple interactions decreases expression increases response to substance |
ISO EXP |
BDNF mRNA results in decreased susceptibility to Cocaine; BDNF protein results in decreased susceptibility to Cocaine Cocaine results in increased expression of BDNF mRNA Cocaine results in decreased activity of BDNF protein Cocaine results in increased expression of BDNF protein Cocaine affects the expression of BDNF exon; Cocaine affects the expression of BDNF mRNA; Cocaine affects the expression of BDNF protein BDNF protein inhibits the reaction [Cocaine results in increased abundance of Amino Acids, Peptides, and Proteins]; Cocaine affects the activity of and affects the expression of BDNF protein; Cocaine affects the reaction [CREB1 modified form binds to BDNF promoter]; Cocaine affects the reaction [MECP2 protein affects the expression of BDNF protein]; Cocaine affects the reaction [MECP2 protein binds to and results in decreased activity of BDNF promoter]; Cocaine affects the reaction [MIR212 protein affects the expression of BDNF protein] BDNF mRNA results in decreased susceptibility to Cocaine; BDNF protein results in decreased susceptibility to Cocaine; BDNF results in decreased susceptibility to Cocaine (+)-JQ1 compound inhibits the reaction [Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]]; (+)-JQ1 compound inhibits the reaction [Cocaine results in increased expression of BDNF mRNA]; Cocaine inhibits the reaction [CREB1 protein binds to BDNF promoter]; Cocaine inhibits the reaction [MECP2 protein binds to BDNF promoter]; Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of BDNF mRNA]; Haloperidol inhibits the reaction [Cocaine results in decreased expression of BDNF protein] Cocaine results in decreased expression of BDNF mRNA; Cocaine results in decreased expression of BDNF protein BDNF results in increased susceptibility to Cocaine |
CTD |
PMID:12099907 PMID:14973246 PMID:16423334 PMID:17194538 PMID:17618281 PMID:18311559 PMID:18355967 PMID:19321768 PMID:20554863 PMID:20711185 PMID:20810894 PMID:20826313 PMID:24358339 PMID:26558777 |
|
NCBI chr 2:109,674,700...109,727,043
Ensembl chr 2:109,674,700...109,727,007
|
|
G |
Begain |
brain-enriched guanylate kinase-associated |
affects expression |
ISO |
Cocaine affects the expression of BEGAIN mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:109,032,181...109,068,242
Ensembl chr12:109,032,187...109,068,217
|
|
G |
Bhlhe22 |
basic helix-loop-helix family, member e22 |
increases expression |
ISO |
Cocaine results in increased expression of BHLHE22 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 3:18,054,325...18,057,514
Ensembl chr 3:18,054,174...18,057,517
|
|
G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
affects expression |
ISO |
Cocaine affects the expression of BHLHE40 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:108,660,629...108,666,925
Ensembl chr 6:108,660,629...108,666,925
|
|
G |
Bid |
BH3 interacting domain death agonist |
affects expression |
EXP |
Cocaine affects the expression of BID mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 6:120,893,119...120,917,062
Ensembl chr 6:120,891,930...120,916,853
|
|
G |
Bik |
BCL2-interacting killer |
affects expression |
EXP |
Cocaine affects the expression of BIK mRNA |
CTD |
PMID:15681117 |
|
NCBI chr15:83,526,790...83,544,635
Ensembl chr15:83,526,862...83,544,634
|
|
G |
Bmp2k |
BMP2 inducible kinase |
affects expression |
ISO |
Cocaine affects the expression of BMP2K mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:96,997,672...97,091,048
Ensembl chr 5:96,997,689...97,091,867
|
|
G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
increases expression |
ISO |
Cocaine results in increased expression of BMPR2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:59,764,279...59,878,081
Ensembl chr 1:59,763,400...59,879,014
|
|
G |
Bnip2 |
BCL2/adenovirus E1B interacting protein 2 |
affects expression |
EXP |
Cocaine affects the expression of BNIP2 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 9:69,989,438...70,011,659
Ensembl chr 9:69,989,466...70,008,317
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
affects expression |
EXP |
Cocaine affects the expression of BNIP3 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 7:138,890,836...138,909,506
Ensembl chr 7:138,890,836...138,909,519
|
|
G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
affects expression |
EXP |
Cocaine affects the expression of BNIP3L mRNA |
CTD |
PMID:15681117 |
|
NCBI chr14:66,985,238...67,008,877
Ensembl chr14:66,985,239...67,008,877
|
|
G |
Brd4 |
bromodomain containing 4 |
multiple interactions increases expression |
EXP ISO |
(+)-JQ1 compound inhibits the reaction [Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter]]; Cocaine promotes the reaction [BRD4 protein binds to BDNF promoter] Cocaine results in increased expression of BRD4 protein |
CTD |
PMID:26558777 |
|
NCBI chr17:32,196,272...32,284,743
Ensembl chr17:32,196,274...32,284,722
|
|
G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
affects expression |
ISO |
Cocaine affects the expression of BSCL2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:8,837,467...8,848,683
Ensembl chr19:8,837,467...8,848,683
|
|
G |
Bst1 |
bone marrow stromal cell antigen 1 |
affects expression |
ISO |
Cocaine affects the expression of BST1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:43,818,880...43,843,468
Ensembl chr 5:43,818,885...43,843,986
|
|
G |
Btbd9 |
BTB (POZ) domain containing 9 |
increases expression |
ISO |
Cocaine results in increased expression of BTBD9 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr17:30,215,524...30,582,621
Ensembl chr17:30,215,524...30,576,488
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
affects expression |
ISO |
Cocaine affects the expression of BTG2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 1:134,074,865...134,079,155
Ensembl chr 1:134,075,170...134,079,120
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
decreases expression |
ISO |
Cocaine results in decreased expression of BTK mRNA |
CTD |
PMID:17898221 |
|
NCBI chr X:134,542,334...134,583,628
Ensembl chr X:134,542,336...134,583,570
|
|
G |
C1qbp |
complement component 1, q subcomponent binding protein |
decreases expression |
ISO |
Cocaine results in decreased expression of C1QBP protein |
CTD |
PMID:25100957 |
|
NCBI chr11:70,977,846...70,983,026
Ensembl chr11:70,977,836...70,983,026
|
|
G |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
affects expression |
ISO |
Cocaine affects the expression of C1QTNF1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:118,428,457...118,451,782
Ensembl chr11:118,428,203...118,449,963
|
|
G |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
decreases expression |
ISO |
Cocaine results in decreased expression of C1QTNF4 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:90,882,788...90,890,526
Ensembl chr 2:90,885,860...90,890,525
|
|
G |
C2cd3 |
C2 calcium-dependent domain containing 3 |
decreases expression |
ISO |
Cocaine results in decreased expression of C2CD3 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 7:100,372,229...100,470,159
Ensembl chr 7:100,372,233...100,470,152
|
|
G |
C2cd4d |
C2 calcium-dependent domain containing 4D |
decreases expression |
ISO |
Cocaine results in decreased expression of C2CD4D mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 3:94,362,444...94,364,567
Ensembl chr 3:94,362,438...94,364,566
|
|
G |
Cab39l |
calcium binding protein 39-like |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CAB39L mRNA |
CTD |
PMID:18355967 |
|
NCBI chr14:59,440,934...59,548,904
Ensembl chr14:59,440,972...59,585,764
|
|
G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
affects response to substance |
ISO |
CACNA1D polymorphism affects the susceptibility to Cocaine |
CTD |
PMID:28194001 |
|
NCBI chr14:30,039,941...30,491,156
Ensembl chr14:30,039,939...30,491,455
|
|
G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
affects expression |
ISO |
Cocaine affects the expression of CACNB3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:98,628,436...98,644,536
Ensembl chr15:98,630,840...98,644,529
|
|
G |
Cald1 |
caldesmon 1 |
affects expression |
ISO |
Cocaine affects the expression of CALD1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:34,598,495...34,775,469
Ensembl chr 6:34,598,500...34,775,473
|
|
G |
Calm1 |
calmodulin 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CALM1 mRNA |
CTD |
PMID:17205118 |
|
NCBI chr12:100,199,435...100,209,824
Ensembl chr12:100,199,435...100,209,814
|
|
G |
Calm2 |
calmodulin 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of CALM2 mRNA |
CTD |
PMID:17205118 |
|
NCBI chr17:87,433,401...87,446,935
Ensembl chr12:100,199,435...100,209,814 Ensembl chr17:100,199,435...100,209,814
|
|
G |
Calr |
calreticulin |
decreases expression multiple interactions affects expression |
EXP ISO |
Cocaine results in decreased expression of CALR mRNA FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of CALR mRNA] Cocaine affects the expression of CALR mRNA |
CTD |
PMID:18355967 PMID:20187946 |
|
NCBI chr 8:84,842,088...84,846,931
Ensembl chr 8:84,841,850...84,846,934
|
|
G |
Caly |
calcyon neuron-specific vesicular protein |
increases expression |
ISO |
Cocaine results in increased expression of CALY mRNA |
CTD |
PMID:20171207 |
|
NCBI chr 7:140,069,880...140,082,571
Ensembl chr 7:140,069,880...140,082,548
|
|
G |
Camk1g |
calcium/calmodulin-dependent protein kinase I gamma |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CAMK1G mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 1:193,346,346...193,370,355
Ensembl chr 1:193,346,346...193,370,298
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
affects response to substance multiple interactions increases expression |
EXP ISO |
CAMK2A affects the susceptibility to Cocaine Cocaine results in increased expression of and results in increased phosphorylation of CAMK2A protein; Nifedipine inhibits the reaction [Cocaine results in increased expression of and results in increased phosphorylation of CAMK2A protein] Cocaine results in increased expression of CAMK2A protein 7-chlorokynurenic acid inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein]; Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]; Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein; KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]]; Sodium Benzoate promotes the reaction [Cocaine results in increased phosphorylation of and results in increased activity of CAMK2A protein] |
CTD |
PMID:14725635 PMID:17609678 PMID:19217379 PMID:28194001 |
|
NCBI chr18:60,925,307...60,988,152
Ensembl chr18:60,925,618...60,988,152
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
decreases expression affects expression |
ISO |
Cocaine results in decreased expression of CAMK2B mRNA Cocaine affects the expression of CAMK2B mRNA |
CTD |
PMID:17205118 PMID:20187946 |
|
NCBI chr11:5,969,629...6,066,357
Ensembl chr11:5,969,644...6,066,362
|
|
G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
increases response to substance decreases response to substance |
ISO EXP |
CAMK4 promoter SNP results in increased susceptibility to Cocaine CAMK4 protein results in decreased susceptibility to Cocaine |
CTD |
PMID:19001277 |
|
NCBI chr18:32,934,941...33,195,767
Ensembl chr18:32,934,931...33,191,228
|
|
G |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
affects expression |
ISO |
Cocaine affects the expression of CAP2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr13:46,501,903...46,650,281
Ensembl chr13:46,501,848...46,650,281
|
|
G |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
decreases expression |
ISO |
Cocaine results in decreased expression of CAPZB mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 4:139,192,899...139,291,820
Ensembl chr 4:139,192,899...139,291,818
|
|
G |
Car4 |
carbonic anhydrase 4 |
decreases expression |
ISO |
Cocaine results in decreased expression of CAR4 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:84,957,754...84,966,054
Ensembl chr11:84,957,786...84,966,044
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
decreases expression |
ISO |
Cocaine results in decreased expression of CARD11 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 5:140,872,999...141,000,596
Ensembl chr 5:140,872,990...141,000,582
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
affects expression |
ISO |
Cocaine affects the expression of CARM1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:21,546,894...21,589,467
Ensembl chr 9:21,546,894...21,592,623
|
|
G |
Carnmt1 |
carnosine N-methyltransferase 1 |
affects expression |
ISO |
Cocaine affects the expression of CARNMT1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:18,670,759...18,707,201
Ensembl chr19:18,670,764...18,707,200
|
|
G |
Cartpt |
CART prepropeptide |
increases expression affects expression |
ISO |
Cocaine results in increased expression of CARTPT mRNA Cocaine affects the expression of CARTPT mRNA |
CTD |
PMID:15009677 PMID:17851536 PMID:20187946 |
|
NCBI chr13:99,898,483...99,910,179
Ensembl chr13:99,898,489...99,901,091
|
|
G |
Casp2 |
caspase 2 |
increases activity increases expression |
ISO |
Cocaine results in increased activity of CASP2 protein Cocaine results in increased expression of CASP2 mRNA |
CTD |
PMID:16076954 PMID:16638611 |
|
NCBI chr 6:42,264,902...42,282,508
Ensembl chr 6:42,264,985...42,282,508
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases cleavage increases activity affects expression |
ISO EXP |
Cocaine results in increased expression of CASP3 protein ADCYAP1 protein modified form affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; IL6 protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; PRKCD protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; rottlerin inhibits the reaction [Cocaine results in increased cleavage of CASP3 protein]; TNF protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; TNF protein affects the reaction [IL6 protein affects the reaction [Cocaine results in increased cleavage of CASP3 protein]] Cocaine results in increased activity of CASP3 protein Cocaine affects the expression of CASP3 protein [Heroin co-treated with Cocaine] results in increased activity of CASP3 protein; Cocaine results in increased cleavage of and results in increased activity of CASP3 protein; Heroin promotes the reaction [Cocaine results in increased activity of CASP3 protein]; SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP3 protein] Cocaine affects the expression of CASP3 mRNA |
CTD |
PMID:10604926 PMID:11392460 PMID:12639677 PMID:14741756 PMID:15365088 PMID:15681117 PMID:16179556 PMID:16638611 PMID:16686379 PMID:17084983 PMID:17635674 PMID:18974856 PMID:19183502 PMID:20600547 PMID:29673861 PMID:30393195 |
|
NCBI chr 8:46,617,291...46,639,698
Ensembl chr 8:46,617,291...46,639,689
|
|
G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
affects expression decreases expression |
EXP ISO |
Cocaine affects the expression of CASP4 mRNA Cocaine results in decreased expression of CASP4 mRNA |
CTD |
PMID:12629581 PMID:15681117 |
|
NCBI chr 9:5,308,849...5,336,791
Ensembl chr 9:5,308,828...5,336,783
|
|
G |
Casp8 |
caspase 8 |
affects expression increases activity |
EXP ISO |
Cocaine affects the expression of CASP8 mRNA Cocaine results in increased activity of CASP8 protein |
CTD |
PMID:11392460 PMID:15681117 PMID:18974856 |
|
NCBI chr 1:58,795,233...58,847,503
Ensembl chr 1:58,795,374...58,847,503
|
|
G |
Casp9 |
caspase 9 |
affects expression increases activity multiple interactions increases expression |
EXP ISO |
Cocaine affects the expression of CASP9 mRNA Cocaine results in increased activity of CASP9 protein SB 203580 inhibits the reaction [Cocaine results in increased activity of CASP9 protein] Cocaine affects the expression of CASP9 protein Cocaine results in increased expression of CASP9 protein |
CTD |
PMID:10604926 PMID:11392460 PMID:12639677 PMID:15365088 PMID:15681117 PMID:16179556 PMID:16638611 PMID:16686379 PMID:17084983 PMID:17635674 PMID:18974856 |
|
NCBI chr 4:141,793,612...141,815,978
Ensembl chr 4:141,793,612...141,815,976
|
|
G |
Castor1 |
cytosolic arginine sensor for mTORC1 subunit 1 |
affects expression |
ISO |
Cocaine affects the expression of CASTOR1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:4,218,166...4,222,409
Ensembl chr11:4,218,225...4,222,409
|
|
G |
Cat |
catalase |
decreases activity increases activity increases expression |
EXP ISO |
Cocaine results in decreased activity of CAT protein Cocaine results in increased activity of CAT protein Cocaine results in increased expression of CAT protein |
CTD |
PMID:14576513 PMID:16085363 PMID:29475069 |
|
NCBI chr 2:103,453,904...103,485,153
Ensembl chr 2:103,453,849...103,485,160
|
|
G |
Catsper2 |
cation channel, sperm associated 2 |
increases expression |
ISO |
Cocaine results in increased expression of CATSPER2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:121,391,633...121,414,598
Ensembl chr 2:121,392,631...121,413,792
|
|
G |
Cbln1 |
cerebellin 1 precursor protein |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in increased expression of CBLN1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 8:87,468,853...87,472,592
Ensembl chr 8:87,468,405...87,472,609
|
|
G |
Ccdc127 |
coiled-coil domain containing 127 |
increases expression |
ISO |
Cocaine results in increased expression of CCDC127 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr13:74,350,317...74,365,783
Ensembl chr13:74,350,309...74,365,783
|
|
G |
Ccdc174 |
coiled-coil domain containing 174 |
affects expression |
ISO |
Cocaine affects the expression of CCDC174 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:91,843,154...91,899,849
Ensembl chr 6:91,878,053...91,899,843
|
|
G |
Ccdc88a |
coiled coil domain containing 88A |
increases expression |
ISO |
Cocaine results in increased expression of CCDC88A mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:29,373,405...29,510,808
Ensembl chr11:29,373,658...29,510,808
|
|
G |
Ccdc93 |
coiled-coil domain containing 93 |
increases expression |
ISO |
Cocaine results in increased expression of CCDC93 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:121,431,067...121,506,460
Ensembl chr 1:121,431,049...121,506,460
|
|
G |
Cckbr |
cholecystokinin B receptor |
decreases expression increases response to substance |
ISO EXP |
Cocaine results in decreased expression of CCKBR mRNA CCKBR protein results in increased susceptibility to Cocaine |
CTD |
PMID:11403953 PMID:18000554 |
|
NCBI chr 7:105,425,676...105,436,339
Ensembl chr 7:105,425,731...105,470,898
|
|
G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
increases secretion increases expression multiple interactions |
ISO EXP |
Cocaine results in increased secretion of CCL2 protein Cocaine results in increased expression of CCL2 protein Cocaine results in increased expression of CCL2 mRNA; Cocaine results in increased expression of CCL2 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; AG 1879 inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; Cocaine promotes the reaction [RELA protein binds to CCL2 promoter]; methyl-beta-cyclodextrin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; pyrazolanthrone inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; RELA mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; SC 514 inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; SIGMAR1 mutant form inhibits the reaction [Cocaine results in increased expression of CCL2 protein]; U 0126 inhibits the reaction [Cocaine results in increased expression of CCL2 protein] |
CTD |
PMID:10065903 PMID:20354174 |
|
NCBI chr11:82,035,577...82,037,452
Ensembl chr11:82,035,571...82,037,453
|
|
G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
increases secretion |
ISO |
Cocaine results in increased secretion of CCL3 protein |
CTD |
PMID:10065903 |
|
NCBI chr11:83,647,843...83,649,378
Ensembl chr11:83,647,844...83,649,355
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of CCN2 mRNA; Cocaine results in decreased expression of CCN2 protein |
CTD |
PMID:18000554 |
|
NCBI chr10:24,595,442...24,598,683
Ensembl chr10:24,595,442...24,598,683
|
|
G |
Ccn3 |
cellular communication network factor 3 |
increases expression |
ISO |
Cocaine results in increased expression of CCN3 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr15:54,745,910...54,753,762
Ensembl chr15:54,745,702...54,754,039
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Cocaine results in decreased expression of CCNA2 mRNA |
CTD |
PMID:18593214 |
|
NCBI chr 3:36,564,865...36,573,038
Ensembl chr 3:36,564,865...36,572,150
|
|
G |
Ccnd1 |
cyclin D1 |
affects expression |
ISO |
Cocaine affects the expression of CCND1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:144,929,931...144,939,831
Ensembl chr 7:144,929,931...144,939,925
|
|
G |
Ccnd3 |
cyclin D3 |
affects expression |
ISO |
Cocaine affects the expression of CCND3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr17:47,505,051...47,599,689
Ensembl chr17:47,505,051...47,599,691
|
|
G |
Ccnl1 |
cyclin L1 |
increases expression |
ISO |
Cocaine results in increased expression of CCNL1 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr 3:65,945,908...65,962,029
Ensembl chr 3:65,946,151...65,958,249
|
|
G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
increases response to substance affects expression |
EXP ISO |
CCR2 results in increased susceptibility to Cocaine Cocaine affects the expression of CCR2 mRNA |
CTD |
PMID:20187946 PMID:20354174 |
|
NCBI chr 9:124,101,918...124,109,140
Ensembl chr 9:124,101,950...124,113,557
|
|
G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
increases expression |
ISO |
Cocaine results in increased expression of CCR5 protein |
CTD |
PMID:16204638 |
|
NCBI chr 9:124,121,543...124,127,183
Ensembl chr 9:124,121,543...124,147,699
|
|
G |
Ccser1 |
coiled-coil serine rich 1 |
affects response to substance |
ISO |
CCSER1 gene SNP affects the susceptibility to Cocaine |
CTD |
PMID:18438686 |
|
NCBI chr 6:61,179,960...62,382,863
Ensembl chr 6:61,180,324...62,382,865
|
|
G |
Cct2 |
chaperonin containing Tcp1, subunit 2 (beta) |
affects expression |
ISO |
Cocaine affects the expression of CCT2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr10:117,050,997...117,063,852
Ensembl chr10:117,051,001...117,063,814
|
|
G |
Ccz1 |
CCZ1 vacuolar protein trafficking and biogenesis associated |
decreases expression |
ISO |
Cocaine results in decreased expression of CCZ1 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 5:143,987,909...144,014,883
Ensembl chr 5:143,987,909...144,014,877
|
|
G |
Cd180 |
CD180 antigen |
decreases expression |
ISO |
Cocaine results in decreased expression of CD180 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr13:102,693,547...102,706,631
Ensembl chr13:102,693,558...102,739,629
|
|
G |
Cd276 |
CD276 antigen |
affects expression |
ISO |
Cocaine affects the expression of CD276 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:58,524,300...58,555,033
Ensembl chr 9:58,524,298...58,555,437
|
|
G |
Cd4 |
CD4 antigen |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of CD4 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 6:124,864,693...124,888,247
Ensembl chr 6:124,864,692...124,888,221
|
|
G |
Cd44 |
CD44 antigen |
decreases expression |
ISO |
Cocaine results in decreased expression of CD44 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr 2:102,811,141...102,901,669
Ensembl chr 2:102,811,141...102,901,665
|
|
G |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
affects expression |
ISO |
Cocaine affects the expression of CD47 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr16:49,851,328...49,912,503
Ensembl chr16:49,800,533...49,915,010
|
|
G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
affects expression |
ISO |
Cocaine affects the expression of CD74 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr18:60,803,849...60,812,652
Ensembl chr18:60,803,848...60,812,652
|
|
G |
Cd81 |
CD81 antigen |
increases response to substance increases expression affects response to substance |
ISO EXP |
CD81 protein results in increased susceptibility to Cocaine Cocaine results in increased expression of CD81 mRNA CD81 protein affects the susceptibility to Cocaine |
CTD |
PMID:11178868 PMID:12113778 PMID:15715673 |
|
NCBI chr 7:143,052,750...143,067,930
Ensembl chr 7:143,052,739...143,067,934
|
|
G |
Cd93 |
CD93 antigen |
decreases expression |
ISO |
Cocaine results in decreased expression of CD93 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:148,436,651...148,443,535
Ensembl chr 2:148,436,640...148,443,563
|
|
G |
Cdc14b |
CDC14 cell division cycle 14B |
decreases expression |
ISO |
Cocaine results in decreased expression of CDC14B mRNA |
CTD |
PMID:17898221 |
|
NCBI chr13:64,192,545...64,274,988
Ensembl chr13:64,189,268...64,275,290
|
|
G |
Cdc25a |
cell division cycle 25A |
increases expression |
ISO |
Cocaine results in increased expression of CDC25A mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 9:109,875,518...109,893,895
Ensembl chr 9:109,875,579...109,893,895
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CDH1 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 8:106,603,350...106,670,247
Ensembl chr 8:106,603,351...106,670,246
|
|
G |
Cdh16 |
cadherin 16 |
affects expression |
ISO |
Cocaine affects the expression of CDH16 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 8:104,601,915...104,624,396
Ensembl chr 8:104,601,911...104,624,396
|
|
G |
Cdh17 |
cadherin 17 |
decreases expression |
ISO |
Cocaine results in decreased expression of CDH17 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 4:11,758,157...11,817,905
Ensembl chr 4:11,758,147...11,817,895
|
|
G |
Cdk18 |
cyclin-dependent kinase 18 |
affects expression |
ISO |
Cocaine affects the expression of CDK18 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 1:132,113,547...132,139,698
Ensembl chr 1:132,112,237...132,139,684
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
affects expression |
EXP |
Cocaine affects the expression of CDK4 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr10:127,063,535...127,067,288
Ensembl chr10:127,063,534...127,067,920
|
|
G |
Cdk5 |
cyclin-dependent kinase 5 |
affects expression increases expression decreases expression |
ISO |
Cocaine affects the expression of CDK5 mRNA; Cocaine affects the expression of CDK5 protein Cocaine results in increased expression of CDK5 mRNA; Cocaine results in increased expression of CDK5 protein Cocaine results in decreased expression of CDK5 protein |
CTD |
PMID:11268215 PMID:12787079 PMID:16263094 PMID:17339080 PMID:17680995 PMID:20187946 |
|
NCBI chr 5:24,407,597...24,423,587
Ensembl chr 5:24,418,241...24,423,530
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
multiple interactions increases expression decreases expression |
EXP ISO |
CDK5R1 protein inhibits the reaction [Cocaine affects the expression of FOS mRNA]; CDK5R1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAP2K2 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAPK1 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of MAPK3 protein]; CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein] Cocaine results in increased expression of CDK5R1 mRNA; Cocaine results in increased expression of CDK5R1 protein Cocaine results in decreased expression of CDK5R1 protein |
CTD |
PMID:11268215 PMID:15665076 PMID:16263094 |
|
NCBI chr11:80,477,023...80,481,184
Ensembl chr11:80,477,023...80,481,184
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
increases expression |
ISO |
Cocaine results in increased expression of CDKN1A mRNA |
CTD |
PMID:27899881 |
|
NCBI chr17:29,090,979...29,100,722
Ensembl chr17:29,090,976...29,100,727
|
|
G |
Ceacam10 |
carcinoembryonic antigen-related cell adhesion molecule 10 |
affects expression |
ISO |
Cocaine affects the expression of CEACAM3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:24,777,167...24,784,656
Ensembl chr 7:24,777,206...24,784,657
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Cocaine results in increased expression of CEL mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 2:28,555,819...28,563,403
Ensembl chr 2:28,555,795...28,563,403
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions increases hydrolysis affects binding |
ISO |
CES1 protein results in increased metabolism of [Cocaine co-treated with Ethanol]; Cocaine inhibits the reaction [CES1 protein results in increased chemical synthesis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-methylumbelliferyl acetate]; Cocaine inhibits the reaction [CES1 protein results in increased hydrolysis of Heroin] CES1 protein results in increased hydrolysis of Cocaine Cocaine binds to CES1 protein |
CTD |
PMID:8930175 PMID:9311626 PMID:12679808 PMID:12773168 PMID:25445008 |
|
NCBI chr 8:93,166,072...93,197,804
Ensembl chr 8:93,166,068...93,197,838
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions decreases expression increases hydrolysis |
ISO |
Cocaine inhibits the reaction [CES2 protein results in increased chemical synthesis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES2 protein results in increased chemical synthesis of Morphine]; Cocaine inhibits the reaction [CES2 protein results in increased hydrolysis of 6-O-monoacetylmorphine]; Cocaine inhibits the reaction [CES2 protein results in increased hydrolysis of Heroin] Cocaine results in decreased expression of CES2 mRNA CES2 protein results in increased hydrolysis of Cocaine |
CTD |
PMID:8930175 PMID:9169443 PMID:12629581 |
|
NCBI chr 8:105,000,830...105,020,410
Ensembl chr 8:105,000,853...105,021,178
|
|
G |
Cfh |
complement component factor h |
decreases expression |
ISO |
Cocaine results in decreased expression of CFH mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:140,085,855...140,183,411
Ensembl chr 1:140,084,708...140,183,764
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
affects expression |
EXP |
Cocaine affects the expression of CFLAR mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 1:58,711,311...58,758,884
Ensembl chr 1:58,711,508...58,758,884
|
|
G |
Chfr |
checkpoint with forkhead and ring finger domains |
affects expression |
ISO |
Cocaine affects the expression of CHFR mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:110,135,755...110,171,973
Ensembl chr 5:110,135,842...110,171,972
|
|
G |
Chn1 |
chimerin 1 |
affects expression |
ISO |
Cocaine affects the expression of CHN1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:73,610,660...73,775,367
Ensembl chr 2:73,610,660...73,775,346
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
affects expression |
ISO |
Cocaine affects the expression of CHRM4 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:91,922,189...91,929,835
Ensembl chr 2:91,927,249...91,928,688
|
|
G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
decreases response to substance |
ISO |
CHRM5 mutant form results in decreased susceptibility to Cocaine |
CTD |
PMID:20393457 |
|
NCBI chr 2:112,478,733...112,536,361
Ensembl chr 2:112,479,171...112,480,769
|
|
G |
Chrna3 |
cholinergic receptor, nicotinic, alpha polypeptide 3 |
multiple interactions |
ISO |
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]] |
CTD |
PMID:10336510 |
|
NCBI chr 9:55,010,117...55,026,562
Ensembl chr 9:55,010,111...55,026,562
|
|
G |
Chrna4 |
cholinergic receptor, nicotinic, alpha polypeptide 4 |
multiple interactions |
ISO |
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] |
CTD |
PMID:10336510 |
|
NCBI chr 2:181,022,311...181,043,579
Ensembl chr 2:181,018,380...181,043,546
|
|
G |
Chrna5 |
cholinergic receptor, nicotinic, alpha polypeptide 5 |
decreases response to substance |
ISO |
CHRNA5 gene polymorphism results in decreased susceptibility to Cocaine |
CTD |
PMID:18519132 |
|
NCBI chr 9:54,980,827...55,011,420
Ensembl chr 9:54,980,880...55,007,779
|
|
G |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
multiple interactions increases response to substance |
ISO EXP |
Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA3 protein binds to CHRNB2 protein]]; Cocaine inhibits the reaction [Nicotine results in increased activity of [CHRNA4 protein binds to CHRNB2 protein]] CHRNB2 protein results in increased susceptibility to Cocaine |
CTD |
PMID:10336510 PMID:11282258 |
|
NCBI chr 3:89,753,448...89,764,632
Ensembl chr 3:89,746,195...89,764,632
|
|
G |
Chrne |
cholinergic receptor, nicotinic, epsilon polypeptide |
increases expression |
ISO |
Cocaine results in increased expression of CHRNE mRNA |
CTD |
PMID:27899881 |
|
NCBI chr11:70,614,883...70,619,213
Ensembl chr11:70,614,883...70,619,216
|
|
G |
Chtf8 |
CTF8, chromosome transmission fidelity factor 8 |
decreases expression |
ISO |
Cocaine results in decreased expression of CHTF8 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 8:106,883,863...106,893,593
Ensembl chr 8:106,883,863...106,893,601 Ensembl chr 8:106,883,863...106,893,601
|
|
G |
Churc1 |
churchill domain containing 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CHURC1 mRNA |
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr12:76,765,538...76,783,180
Ensembl chr12:76,765,538...76,783,180
|
|
G |
Ciao1 |
cytosolic iron-sulfur protein assembly 1 |
affects expression |
ISO |
Cocaine affects the expression of CIAO1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:127,240,938...127,247,816
Ensembl chr 2:127,240,938...127,247,816
|
|
G |
Cidea |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector A |
affects expression |
EXP |
Cocaine affects the expression of CIDEA mRNA |
CTD |
PMID:15681117 |
|
NCBI chr18:67,343,564...67,367,794
Ensembl chr18:67,343,604...67,367,785
|
|
G |
Cideb |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
affects expression |
EXP |
Cocaine affects the expression of CIDEB mRNA |
CTD |
PMID:15681117 |
|
NCBI chr14:55,754,052...55,758,424
Ensembl chr14:55,754,050...55,758,458
|
|
G |
Cisd1 |
CDGSH iron sulfur domain 1 |
increases expression |
ISO |
Cocaine results in increased expression of CISD1 protein |
CTD |
PMID:25100957 |
|
NCBI chr10:71,330,494...71,344,849
Ensembl chr10:71,330,480...71,344,954
|
|
G |
Cisd2 |
CDGSH iron sulfur domain 2 |
increases expression |
ISO |
Cocaine results in increased expression of CISD2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 3:135,406,412...135,424,039
Ensembl chr 3:135,406,412...135,423,925
|
|
G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
decreases expression |
ISO |
Cocaine results in decreased expression of CITED4 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 4:120,666,563...120,667,820
Ensembl chr 4:120,666,572...120,667,820
|
|
G |
Ckb |
creatine kinase, brain |
multiple interactions |
ISO |
Cocaine results in increased secretion of [CKB protein binds to CKM protein] |
CTD |
PMID:12359538 |
|
NCBI chr12:111,669,355...111,672,338
Ensembl chr12:111,669,361...111,672,338
|
|
G |
Ckm |
creatine kinase, muscle |
multiple interactions |
ISO |
Cocaine results in increased secretion of [CKB protein binds to CKM protein] |
CTD |
PMID:12359538 |
|
NCBI chr 7:19,411,094...19,421,583
Ensembl chr 7:19,404,776...19,422,841
|
|
G |
Ckmt1 |
creatine kinase, mitochondrial 1, ubiquitous |
affects expression |
ISO |
Cocaine affects the expression of CKMT1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:121,357,773...121,363,737
Ensembl chr 2:121,357,714...121,363,737
|
|
G |
Clcn7 |
chloride channel, voltage-sensitive 7 |
affects expression |
ISO |
Cocaine affects the expression of CLCN7 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr17:25,133,378...25,162,103
Ensembl chr17:25,133,391...25,162,104
|
|
G |
Cldn11 |
claudin 11 |
decreases expression |
ISO |
Cocaine results in decreased expression of CLDN11 mRNA |
CTD |
PMID:18357522 |
|
NCBI chr 3:31,149,920...31,164,326
Ensembl chr 3:31,149,920...31,164,324
|
|
G |
Clec4f |
C-type lectin domain family 4, member f |
affects expression |
ISO |
Cocaine affects the expression of CLEC4F mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:83,644,542...83,656,116
Ensembl chr 6:83,644,542...83,656,187
|
|
G |
Clic1 |
chloride intracellular channel 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CLIC1 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr17:35,050,243...35,058,719
Ensembl chr17:35,049,966...35,058,749
|
|
G |
Clip1 |
CAP-GLY domain containing linker protein 1 |
increases expression |
ISO |
Cocaine results in increased expression of CLIP1 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr 5:123,577,794...123,684,606
Ensembl chr 5:123,577,795...123,684,618
|
|
G |
Clk1 |
CDC-like kinase 1 |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of CLK1 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CLK1 mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr 1:58,411,988...58,424,088
Ensembl chr 1:58,410,189...58,424,066
|
|
G |
Clk4 |
CDC like kinase 4 |
increases expression |
EXP |
Cocaine results in increased expression of CLK4 mRNA |
CTD |
PMID:20056891 |
|
NCBI chr11:51,263,114...51,281,770
Ensembl chr11:51,261,730...51,281,766
|
|
G |
Clock |
circadian locomotor output cycles kaput |
increases expression |
EXP |
Cocaine results in increased expression of CLOCK mRNA |
CTD |
PMID:15994025 |
|
NCBI chr 5:76,209,868...76,305,603
Ensembl chr 5:76,209,868...76,304,792
|
|
G |
Cltb |
clathrin, light polypeptide (Lcb) |
decreases expression |
ISO |
Cocaine results in decreased expression of CLTB mRNA |
CTD |
PMID:12629581 PMID:15009677 |
|
NCBI chr13:54,592,386...54,611,373
Ensembl chr13:54,592,401...54,611,344
|
|
G |
Clybl |
citrate lyase beta like |
increases expression |
ISO |
Cocaine results in increased expression of CLYBL protein |
CTD |
PMID:25100957 |
|
NCBI chr14:122,170,994...122,402,234
Ensembl chr14:122,181,704...122,402,234
|
|
G |
Cnbd2 |
cyclic nucleotide binding domain containing 2 |
increases expression |
ISO |
Cocaine results in increased expression of CNBD2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:156,311,946...156,375,638
Ensembl chr 2:156,312,299...156,375,638
|
|
G |
Cnksr2 |
connector enhancer of kinase suppressor of Ras 2 |
increases expression |
ISO |
Cocaine results in increased expression of CNKSR2 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr X:157,821,430...158,044,458
Ensembl chr X:157,821,436...158,043,294
|
|
G |
Cnr1 |
cannabinoid receptor 1 (brain) |
affects response to substance increases activity decreases response to substance multiple interactions |
ISO EXP |
CNR1 gene polymorphism affects the susceptibility to Cocaine; CNR1 gene SNP affects the susceptibility to Cocaine; CNR1 polymorphism affects the susceptibility to Cocaine Cocaine results in increased activity of CNR1 protein CNR1 mutant form results in decreased susceptibility to Cocaine CNR1 gene mutant form inhibits the reaction [Cocaine results in increased phosphorylation of PPP1R1B protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased expression of FOS protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:9106242 PMID:16314880 PMID:17596442 PMID:19052543 PMID:20554863 |
|
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
|
|
G |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
increases expression |
EXP |
Cocaine results in increased expression of CNR2 mRNA |
CTD |
PMID:18286196 |
|
NCBI chr 4:135,895,189...135,920,219
Ensembl chr 4:135,895,394...135,920,207
|
|
G |
Cobll1 |
Cobl-like 1 |
increases expression |
EXP |
Cocaine results in increased expression of COBLL1 mRNA |
CTD |
PMID:27506785 |
|
NCBI chr 2:65,088,339...65,239,398
Ensembl chr 2:65,088,339...65,239,403
|
|
G |
Coil |
coilin |
affects expression |
ISO |
Cocaine affects the expression of COIL mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:88,973,935...88,991,613
Ensembl chr11:88,970,252...88,991,613
|
|
G |
Col15a1 |
collagen, type XV, alpha 1 |
affects expression |
ISO |
Cocaine affects the expression of COL15A1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 4:47,207,655...47,313,167
Ensembl chr 4:47,208,161...47,313,167
|
|
G |
Col1a1 |
collagen, type I, alpha 1 |
increases expression |
ISO |
Cocaine results in increased expression of COL1A1 mRNA |
CTD |
PMID:9455993 |
|
NCBI chr11:94,936,224...94,953,042
Ensembl chr11:94,936,224...94,953,042
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
increases expression |
ISO |
Cocaine results in increased expression of COL3A1 mRNA |
CTD |
PMID:9455993 |
|
NCBI chr 1:45,311,538...45,349,706
Ensembl chr 1:45,311,538...45,349,706
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
affects expression |
ISO |
Cocaine affects the expression of COQ6 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:84,361,756...84,373,796
Ensembl chr12:84,361,657...84,373,796
|
|
G |
Coro7 |
coronin 7 |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of CORO7 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr16:4,626,884...4,679,720
Ensembl chr16:4,626,133...4,679,777
|
|
G |
Cox20 |
cytochrome c oxidase assembly protein 20 |
decreases expression |
ISO |
Cocaine results in decreased expression of COX20 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:178,318,095...178,322,693
Ensembl chr 1:178,319,130...178,322,693
|
|
G |
Cox5a |
cytochrome c oxidase subunit 5A |
affects expression |
ISO |
Cocaine affects the expression of COX5A mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:57,517,328...57,532,427
Ensembl chr 9:57,521,274...57,532,426
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
affects expression increases expression |
ISO |
Cocaine affects the expression of COX6A1 mRNA Cocaine results in increased expression of COX6A1 protein |
CTD |
PMID:20187946 PMID:25100957 |
|
NCBI chr 5:115,345,652...115,348,958
Ensembl chr 5:115,345,642...115,348,981
|
|
G |
Cox6c |
cytochrome c oxidase subunit 6C |
decreases expression |
ISO |
Cocaine results in decreased expression of COX6C mRNA |
CTD |
PMID:12629581 |
|
NCBI chr15:35,931,976...35,938,246
Ensembl chr15:35,925,886...35,938,246
|
|
G |
Cox7b |
cytochrome c oxidase subunit 7B |
affects expression |
ISO |
Cocaine affects the expression of COX7B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr X:106,015,700...106,022,450
Ensembl chr X:106,015,700...106,022,450
|
|
G |
Cox8a |
cytochrome c oxidase subunit 8A |
affects expression |
ISO |
Cocaine affects the expression of COX8A mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:7,215,158...7,217,616
Ensembl chr19:7,215,153...7,217,616
|
|
G |
Cplx1 |
complexin 1 |
affects expression |
ISO |
Cocaine affects the expression of CPLX1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:108,518,554...108,550,027
Ensembl chr 5:108,518,554...108,550,024
|
|
G |
Cpne8 |
copine VIII |
increases expression |
ISO |
Cocaine results in increased expression of CPNE8 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr15:90,487,481...90,679,388
Ensembl chr15:90,487,482...90,679,432
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
affects expression increases phosphorylation multiple interactions affects phosphorylation increases expression |
ISO EXP |
Cocaine affects the expression of CREB1 mRNA Cocaine results in increased phosphorylation of CREB1 protein CDK5R1 protein inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; Cocaine inhibits the reaction [CREB1 protein binds to BDNF promoter]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of CREB1 protein]; RPS6KA3 gene mutant form inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein]; SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein] Cocaine affects the phosphorylation of CREB1 protein Betaxolol affects the reaction [Cocaine affects the phosphorylation of CREB1 protein]; Cocaine affects the reaction [CREB1 modified form binds to BDNF promoter]; Cocaine promotes the reaction [RPS6KA1 protein binds to CREB1 protein]; Cocaine results in increased phosphorylation of and results in increased activity of CREB1 protein; U 0126 inhibits the reaction [Cocaine results in increased phosphorylation of CREB1 protein] |
CTD |
PMID:12595601 PMID:15470197 PMID:15665076 PMID:16219028 PMID:16339038 PMID:16710312 PMID:18596687 PMID:20187946 PMID:20810894 PMID:24358339 |
|
NCBI chr 1:64,532,794...64,604,548
Ensembl chr 1:64,532,645...64,604,548
|
|
G |
Crebbp |
CREB binding protein |
increases expression |
ISO |
Cocaine results in increased expression of CREBBP mRNA |
CTD |
PMID:17898221 |
|
NCBI chr16:4,081,334...4,213,957
Ensembl chr16:4,081,328...4,213,997
|
|
G |
Crebrf |
CREB3 regulatory factor |
increases expression |
ISO |
Cocaine results in increased expression of CREBRF mRNA |
CTD |
PMID:17898221 |
|
NCBI chr17:26,715,594...26,776,637
Ensembl chr17:26,715,650...26,776,635
|
|
G |
Crem |
cAMP responsive element modulator |
affects expression increases expression |
EXP ISO |
Cocaine affects the expression of CREM mRNA Cocaine results in increased expression of CREM mRNA |
CTD |
PMID:18355967 PMID:27899881 |
|
NCBI chr18:3,266,354...3,337,773
Ensembl chr18:3,266,048...3,337,748
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions affects expression |
ISO |
Betaxolol affects the reaction [Cocaine affects the expression of CRH mRNA]; Cocaine affects the reaction [CRH protein affects the secretion of Excitatory Amino Acid Agents]; SCH 23390 affects the reaction [Cocaine affects the expression of CRH mRNA] Cocaine affects the expression of CRH mRNA; Cocaine affects the expression of CRH protein |
CTD |
PMID:7796157 PMID:11597771 PMID:12782395 PMID:15930388 PMID:18596687 |
|
NCBI chr 3:19,693,401...19,695,396
Ensembl chr 3:19,693,401...19,695,396
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
increases expression |
ISO |
Cocaine results in increased expression of CRHBP mRNA |
CTD |
PMID:27899881 |
|
NCBI chr13:95,431,376...95,444,831
Ensembl chr13:95,431,371...95,444,924
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
increases expression |
ISO |
Cocaine results in increased expression of CRHR1 protein |
CTD |
PMID:17079348 |
|
NCBI chr11:104,130,463...104,175,523
Ensembl chr11:104,132,855...104,175,523
|
|
G |
Crip2 |
cysteine rich protein 2 |
affects expression |
ISO |
Cocaine affects the expression of CRIP2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:113,140,236...113,145,506
Ensembl chr12:113,140,236...113,145,506
|
|
G |
Crispld1 |
cysteine-rich secretory protein LCCL domain containing 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CRISPLD1 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 1:17,727,029...17,767,235
Ensembl chr 1:17,727,045...17,766,344
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
increases expression |
ISO |
Cocaine results in increased expression of CRP protein |
CTD |
PMID:11988210 |
|
NCBI chr 1:172,698,056...172,699,966
Ensembl chr 1:172,698,055...172,833,031
|
|
G |
Crtac1 |
cartilage acidic protein 1 |
affects expression |
ISO |
Cocaine affects the expression of CRTAC1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:42,283,035...42,432,966
Ensembl chr19:42,268,287...42,431,785
|
|
G |
Crtc1 |
CREB regulated transcription coactivator 1 |
multiple interactions |
ISO |
[[Cocaine results in increased expression of MIR212 mRNA] which results in increased activity of RAF1 protein] which results in increased expression of CRTC1 protein |
CTD |
PMID:20613834 |
|
NCBI chr 8:70,382,352...70,439,702
Ensembl chr 8:70,382,355...70,439,579
|
|
G |
Cry1 |
cryptochrome 1 (photolyase-like) |
decreases expression |
EXP |
Cocaine results in decreased expression of CRY1 mRNA |
CTD |
PMID:15994025 |
|
NCBI chr10:85,131,700...85,185,054
Ensembl chr10:85,131,700...85,185,064
|
|
G |
Cry2 |
cryptochrome 2 (photolyase-like) |
decreases expression |
EXP |
Cocaine results in decreased expression of CRY2 mRNA |
CTD |
PMID:15994025 |
|
NCBI chr 2:92,403,646...92,434,085
Ensembl chr 2:92,403,646...92,434,043
|
|
G |
Cryab |
crystallin, alpha B |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of CRYAB mRNA Cocaine results in increased expression of CRYAB mRNA |
CTD |
PMID:15009677 PMID:27899881 |
|
NCBI chr 9:50,745,951...50,756,636
Ensembl chr 9:50,751,325...50,756,636
|
|
G |
Crybb2 |
crystallin, beta B2 |
decreases expression |
ISO |
Cocaine results in decreased expression of CRYBB2 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 5:113,058,258...113,070,117
Ensembl chr 5:113,058,258...113,070,117
|
|
G |
Csad |
cysteine sulfinic acid decarboxylase |
affects expression decreases expression |
ISO |
Cocaine affects the expression of CSAD mRNA Cocaine results in decreased expression of CSAD protein |
CTD |
PMID:20187946 PMID:25100957 |
|
NCBI chr15:102,176,997...102,205,052
Ensembl chr15:102,176,999...102,204,724
|
|
G |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
decreases expression |
ISO |
Cocaine results in decreased expression of CSF2RA mRNA |
CTD |
PMID:17898221 |
|
NCBI chr19:61,217,191...61,228,461
Ensembl chr19:61,223,957...61,228,429
|
|
G |
Csn3 |
casein kappa |
affects expression |
ISO |
Cocaine affects the expression of CSN3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:87,925,579...87,932,550
Ensembl chr 5:87,925,579...87,932,665
|
|
G |
Csnk2a1 |
casein kinase 2, alpha 1 polypeptide |
decreases expression |
ISO |
Cocaine results in decreased expression of CSNK2A1 mRNA |
CTD |
PMID:12117546 |
|
NCBI chr 2:152,226,535...152,281,856
Ensembl chr 2:152,226,839...152,281,852
|
|
G |
Cspg5 |
chondroitin sulfate proteoglycan 5 |
affects expression |
ISO |
Cocaine affects the expression of CSPG5 mRNA; Cocaine affects the expression of CSPG5 protein |
CTD |
PMID:12358776 |
|
NCBI chr 9:110,243,783...110,262,576
Ensembl chr 9:110,243,783...110,262,576
|
|
G |
Csrp2 |
cysteine and glycine-rich protein 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of CSRP2 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr10:110,920,176...110,939,514
Ensembl chr10:110,919,789...110,939,622
|
|
G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
affects expression |
ISO |
Cocaine affects the expression of CTDNEP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:69,981,168...69,990,601
Ensembl chr11:69,981,156...69,990,601
|
|
G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
affects expression multiple interactions |
ISO |
Cocaine affects the expression of CTNNB1 mRNA Cocaine deficiency promotes the reaction [SMARCA4 protein binds to CTNNB1 promoter] |
CTD |
PMID:20187946 PMID:27422367 |
|
NCBI chr 9:120,933,400...120,960,507
Ensembl chr 9:120,929,216...120,960,507
|
|
G |
Ctnnbip1 |
catenin beta interacting protein 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CTNNBIP1 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr 4:149,518,241...149,566,437
Ensembl chr 4:149,518,236...149,566,437
|
|
G |
Ctnnd2 |
catenin (cadherin associated protein), delta 2 |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of CTNND2 mRNA Cocaine results in increased expression of CTNND2 mRNA |
CTD |
PMID:12629581 PMID:16076954 |
|
NCBI chr15:30,172,534...31,029,344
Ensembl chr15:30,172,593...31,029,341
|
|
G |
Ctrl |
chymotrypsin-like |
affects expression increases expression |
ISO |
Cocaine affects the expression of CTRL mRNA Cocaine results in increased expression of CTRL mRNA |
CTD |
PMID:20187946 PMID:27899881 |
|
NCBI chr 8:105,931,994...105,933,862
Ensembl chr 8:105,932,003...105,933,862
|
|
G |
Ctsb |
cathepsin B |
affects expression multiple interactions increases expression |
EXP |
Cocaine affects the expression of CTSB mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CTSB mRNA] |
CTD |
PMID:15681117 PMID:18355967 |
|
NCBI chr14:63,122,462...63,145,923
Ensembl chr14:63,122,462...63,145,923
|
|
G |
Ctsd |
cathepsin D |
affects expression increases expression |
EXP ISO |
Cocaine affects the expression of CTSD mRNA Cocaine results in increased expression of CTSD protein |
CTD |
PMID:15681117 PMID:25100957 |
|
NCBI chr 7:142,375,910...142,387,827
Ensembl chr 7:142,375,911...142,388,038
|
|
G |
Cuedc1 |
CUE domain containing 1 |
multiple interactions |
EXP |
HDAC5 affects the reaction [Cocaine affects the expression of CUEDC1 mRNA] |
CTD |
PMID:17988634 |
|
NCBI chr11:88,099,146...88,194,140
Ensembl chr11:88,098,058...88,194,140
|
|
G |
Cul4b |
cullin 4B |
increases expression |
ISO |
Cocaine results in increased expression of CUL4B mRNA |
CTD |
PMID:15009677 |
|
NCBI chr X:38,531,616...38,576,196
Ensembl chr X:38,533,274...38,576,196
|
|
G |
Cwf19l2 |
CWF19-like 2, cell cycle control (S. pombe) |
increases expression |
ISO |
Cocaine results in increased expression of CWF19L2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 9:3,403,592...3,479,236
Ensembl chr 9:3,403,592...3,479,236
|
|
G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
increases expression |
ISO |
Cocaine results in increased expression of CX3CL1 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr 8:94,772,180...94,782,427
Ensembl chr 8:94,772,009...94,782,427
|
|
G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
increases secretion |
ISO |
Cocaine results in increased secretion of CXCL10 protein |
CTD |
PMID:10065903 |
|
NCBI chr 5:92,346,638...92,348,889
Ensembl chr 5:92,346,638...92,348,889
|
|
G |
Cxcl15 |
chemokine (C-X-C motif) ligand 15 |
increases secretion |
ISO |
Cocaine results in increased secretion of CXCL8 protein |
CTD |
PMID:10065903 |
|
NCBI chr 5:90,794,534...90,803,067
Ensembl chr 5:90,794,534...90,803,067
|
|
G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
decreases expression |
ISO |
Cocaine results in decreased expression of CXCL9 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 5:92,321,331...92,328,079
Ensembl chr 5:92,321,347...92,328,079
|
|
G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
increases expression |
ISO |
Cocaine results in increased expression of CXCR4 protein |
CTD |
PMID:16204638 |
|
NCBI chr 1:128,588,199...128,592,299
Ensembl chr 1:128,588,199...128,592,293
|
|
G |
Cxxc5 |
CXXC finger 5 |
affects expression |
ISO |
Cocaine affects the expression of CXXC5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr18:35,829,379...35,861,693
Ensembl chr18:35,829,397...35,861,688
|
|
G |
Cyba |
cytochrome b-245, alpha polypeptide |
increases expression |
EXP |
Cocaine results in increased expression of CYBA protein |
CTD |
PMID:18952886 |
|
NCBI chr 8:122,424,771...122,432,940
Ensembl chr 8:122,424,776...122,432,930
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
increases expression increases response to substance |
EXP |
Cocaine results in increased expression of CYBB protein CYBB results in increased susceptibility to Cocaine |
CTD |
PMID:18952886 |
|
NCBI chr X:9,435,252...9,487,766
Ensembl chr X:9,435,252...9,487,771
|
|
G |
Cyc1 |
cytochrome c-1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYC1 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr15:76,343,513...76,346,260
Ensembl chr15:76,343,523...76,346,260
|
|
G |
Cycs |
cytochrome c, somatic |
affects expression multiple interactions |
EXP ISO |
Cocaine affects the expression of CYCS mRNA Minocycline inhibits the reaction [Cocaine results in increased secretion of CYCS protein] |
CTD |
PMID:15681117 PMID:21424555 |
|
NCBI chr 6:50,562,563...50,566,569
Ensembl chr 6:50,562,563...50,566,538
|
|
G |
Cygb |
cytoglobin |
decreases expression |
ISO |
Cocaine results in decreased expression of CYGB protein |
CTD |
PMID:25100957 |
|
NCBI chr11:116,645,595...116,654,504
Ensembl chr11:116,645,595...116,654,313
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 9:54,165,937...54,268,164
Ensembl chr 9:54,165,937...54,268,110
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
EXP |
Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP1A1 protein]; Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP1A1 protein] |
CTD |
PMID:11856816 |
|
NCBI chr 9:57,687,928...57,703,824
Ensembl chr 9:57,687,928...57,703,824
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
affects expression |
ISO |
Cocaine affects the expression of CYP26A1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr19:37,697,738...37,701,536
Ensembl chr19:37,697,798...37,701,536
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
decreases response to substance |
ISO |
CYP26B1 protein results in decreased susceptibility to Cocaine |
CTD |
PMID:27899881 |
|
NCBI chr 6:84,571,414...84,593,908
Ensembl chr 6:84,571,414...84,593,908
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYP2C8 mRNA; Cocaine results in decreased expression of CYP2C8 protein |
CTD |
PMID:16188404 |
|
NCBI chr19:39,287,044...39,330,713
Ensembl chr19:39,269,405...39,330,713
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYP2C9 mRNA; Cocaine results in decreased expression of CYP2C9 protein |
CTD |
PMID:16188404 |
|
NCBI chr19:39,061,006...39,093,948
Ensembl chr19:39,061,015...39,093,944
|
|
G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYP2C9 mRNA; Cocaine results in decreased expression of CYP2C9 protein |
CTD |
PMID:16188404 |
|
NCBI chr19:39,113,898...39,186,756
Ensembl chr19:39,113,898...39,187,072
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of CYP2J2 protein Cimetidine inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein]; Metyrapone inhibits the reaction [Cocaine results in increased expression of CYP2J2 protein] |
CTD |
PMID:11856816 |
|
NCBI chr 4:96,568,424...96,592,523
Ensembl chr 4:96,568,429...96,591,578
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
decreases expression |
ISO |
Cocaine results in decreased expression of CYP51 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 5:4,080,674...4,104,697
Ensembl chr 5:4,081,145...4,104,746
|
|
G |
Dab2ip |
disabled 2 interacting protein |
decreases expression |
ISO |
Cocaine results in decreased expression of DAB2IP mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:35,558,446...35,730,994
Ensembl chr 2:35,558,266...35,730,994
|
|
G |
Dazap1 |
DAZ associated protein 1 |
affects expression |
ISO |
Cocaine affects the expression of DAZAP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr10:80,261,362...80,288,408
Ensembl chr10:80,261,486...80,288,408
|
|
G |
Dbh |
dopamine beta hydroxylase |
increases response to substance decreases response to substance |
ISO EXP |
DBH gene polymorphism results in increased susceptibility to Cocaine DBH gene mutant form results in decreased susceptibility to Cocaine |
CTD |
PMID:10673769 PMID:12555232 PMID:18083142 |
|
NCBI chr 2:27,165,507...27,183,204
Ensembl chr 2:27,165,233...27,183,200
|
|
G |
Dbn1 |
drebrin 1 |
multiple interactions |
ISO |
Cocaine deficiency promotes the reaction [SMARCA4 protein binds to DBN1 promoter] |
CTD |
PMID:27422367 |
|
NCBI chr13:55,473,428...55,488,126
Ensembl chr13:55,473,429...55,488,111
|
|
G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
affects expression |
ISO |
Cocaine affects the expression of DCAF8 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 1:172,148,015...172,196,393
Ensembl chr 1:172,148,084...172,197,005
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
affects expression increases expression |
EXP ISO |
Cocaine affects the expression of DDIT3 mRNA Cocaine results in increased expression of DDIT3 mRNA |
CTD |
PMID:15681117 PMID:20187946 PMID:23644055 |
|
NCBI chr10:127,290,793...127,296,291
Ensembl chr10:127,290,774...127,296,288 Ensembl chr10:127,290,774...127,296,288
|
|
G |
Ddr2 |
discoidin domain receptor family, member 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of DDR2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:169,972,307...170,110,836
Ensembl chr 1:169,972,307...170,110,762
|
|
G |
Ddx41 |
DEAD box helicase 41 |
decreases expression |
ISO |
Cocaine results in decreased expression of DDX41 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr13:55,530,410...55,536,658
Ensembl chr13:55,530,410...55,536,658
|
|
G |
Ddx50 |
DExD box helicase 50 |
affects expression |
ISO |
Cocaine affects the expression of DDX50 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr10:62,615,792...62,658,764
Ensembl chr10:62,615,895...62,651,218
|
|
G |
Ddx6 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 |
increases expression |
ISO |
Cocaine results in increased expression of DDX6 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 9:44,602,983...44,640,731
Ensembl chr 9:44,604,892...44,640,731
|
|
G |
Deaf1 |
DEAF1, transcription factor |
decreases expression |
ISO |
Cocaine results in decreased expression of DEAF1 mRNA |
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr 7:141,297,176...141,338,869
Ensembl chr 7:141,297,180...141,327,690
|
|
G |
Dhh |
desert hedgehog |
affects expression |
ISO |
Cocaine affects the expression of DHH mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:98,881,615...98,898,562
Ensembl chr15:98,891,152...98,898,540
|
|
G |
Dhx30 |
DEAH (Asp-Glu-Ala-His) box polypeptide 30 |
affects expression |
ISO |
Cocaine affects the expression of DHX30 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:110,084,319...110,117,616
Ensembl chr 9:110,084,320...110,117,830
|
|
G |
Dipk1b |
divergent protein kinase domain 1B |
affects expression |
ISO |
Cocaine affects the expression of DIPK1B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:26,628,457...26,636,497
Ensembl chr 2:26,628,457...26,636,497
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
increases expression |
ISO |
Cocaine results in increased expression of DLG2 protein |
CTD |
PMID:25100957 |
|
NCBI chr 7:90,476,188...92,449,246
Ensembl chr 7:90,476,672...92,449,247
|
|
G |
Dlg4 |
discs large MAGUK scaffold protein 4 |
affects expression increases expression multiple interactions decreases response to substance decreases expression |
ISO EXP |
Cocaine affects the expression of DLG4 mRNA; Cocaine affects the expression of DLG4 protein Cocaine results in increased expression of DLG4 protein ILK mutant form inhibits the reaction [Cocaine results in increased expression of DLG4 protein] DLG4 protein results in decreased susceptibility to Cocaine Cocaine results in decreased expression of DLG4 mRNA |
CTD |
PMID:14980210 PMID:19629758 PMID:20187946 PMID:20534846 PMID:20600170 |
|
NCBI chr11:70,017,203...70,045,535
Ensembl chr11:70,016,942...70,047,522
|
|
G |
Dlk2 |
delta like non-canonical Notch ligand 2 |
decreases expression multiple interactions |
EXP |
Cocaine results in decreased expression of DLK2 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of DLK2 mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr17:46,297,256...46,303,271
Ensembl chr17:46,297,421...46,303,271
|
|
G |
Dnah8 |
dynein, axonemal, heavy chain 8 |
affects response to substance |
ISO |
DNAH8 gene SNP affects the susceptibility to Cocaine |
CTD |
PMID:18438686 |
|
NCBI chr17:30,626,935...30,875,762
Ensembl chr17:30,624,354...30,877,365
|
|
G |
Dnm1 |
dynamin 1 |
affects expression |
ISO |
Cocaine affects the expression of DNM1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:32,308,471...32,353,349
Ensembl chr 2:32,308,471...32,353,338
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions increases phosphorylation |
ISO EXP |
[Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to DNM1L promoter] Cocaine results in increased phosphorylation of DNM1L protein |
CTD |
PMID:30158054 PMID:31494168 |
|
NCBI chr16:16,312,228...16,359,038
Ensembl chr16:16,312,230...16,358,959
|
|
G |
Dnm2 |
dynamin 2 |
affects expression |
ISO |
Cocaine affects the expression of DNM2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:21,424,908...21,507,759
Ensembl chr 9:21,424,908...21,507,759
|
|
G |
Dnm3 |
dynamin 3 |
affects expression |
ISO |
Cocaine affects the expression of DNM3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 1:161,982,450...162,478,321
Ensembl chr 1:161,982,453...162,478,034
|
|
G |
Dnmbp |
dynamin binding protein |
decreases expression |
ISO |
Cocaine results in decreased expression of DNMBP mRNA |
CTD |
PMID:17898221 |
|
NCBI chr19:43,846,815...43,940,232
Ensembl chr19:43,846,821...43,940,191
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
decreases expression multiple interactions |
EXP |
Cocaine results in decreased expression of DNMT3B mRNA; Cocaine results in decreased expression of DNMT3B protein Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B mRNA]; Methionine inhibits the reaction [Cocaine results in decreased expression of DNMT3B protein] |
CTD |
PMID:22438930 |
|
NCBI chr 2:153,649,411...153,687,730
Ensembl chr 2:153,649,450...153,687,730
|
|
G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of DNPH1 mRNA |
CTD |
PMID:15009677 PMID:16710320 |
|
NCBI chr17:46,496,789...46,499,618
Ensembl chr17:46,496,711...46,499,624
|
|
G |
Dpf2 |
D4, zinc and double PHD fingers family 2 |
increases expression |
ISO |
Cocaine results in increased expression of DPF2 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr19:5,896,516...5,912,871
Ensembl chr19:5,896,516...5,913,010
|
|
G |
Dpysl2 |
dihydropyrimidinase-like 2 |
multiple interactions |
ISO |
[Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of DPYSL2 protein |
CTD |
PMID:19457111 |
|
NCBI chr14:66,802,864...66,911,041
Ensembl chr14:66,802,864...66,868,688
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
affects expression |
ISO |
Cocaine affects the expression of DPYSL3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr18:43,320,979...43,438,286
Ensembl chr18:43,320,984...43,438,286
|
|
G |
Drd1 |
dopamine receptor D1 |
multiple interactions decreases expression affects response to substance affects expression increases response to substance decreases response to substance |
ISO EXP |
1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; 1-propyl-5-(3-p-tolylisoxazol-5-yl)-1,2,3,6-tetrahydropyridine inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; [Cocaine binds to SIGMAR1 protein] affects the folding of [SIGMAR1 protein binds to DRD1 protein]; Cocaine affects the localization of [DRD1 protein binds to SIGMAR1 protein]; Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Cocaine promotes the reaction [DRD1 protein binds to SIGMAR1 protein]; SCH 23390 inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; SCH 23390 inhibits the reaction [Cocaine promotes the reaction [[SIGMAR1 protein binds to DRD1 protein] which results in increased phosphorylation of and results in increased activity of MAPK3 protein]] Cocaine results in decreased expression of DRD1 protein DRD1 protein affects the susceptibility to Cocaine Cocaine affects the expression of DRD1 protein DRD1 results in increased susceptibility to Cocaine Cocaine promotes the reaction [DRD1 protein results in increased expression of FOS protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of NEO1 protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of PDYN protein]; Cocaine promotes the reaction [DRD1 protein results in increased expression of SYT7 protein]; Cocaine promotes the reaction [DRD1 protein results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Cocaine promotes the reaction [DRD1 protein results in increased phosphorylation of and results in increased activity of MAPK3 protein]; DRD1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; DRD1 mutant form inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] DRD1 gene mutant form results in decreased susceptibility to Cocaine [anhydroecgonine methyl ester co-treated with Cocaine] results in decreased expression of DRD1 protein; [SCH 23390 binds to and results in decreased activity of DRD1 protein] inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine affects the reaction [SCH 23390 binds to DRD1 protein]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein alternative form]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein] |
CTD |
PMID:2213551 PMID:8001143 PMID:11421588 PMID:11602327 PMID:15049517 PMID:15056714 PMID:16674926 PMID:17161392 PMID:20435100 PMID:20456009 PMID:20956312 PMID:27129946 |
|
NCBI chr13:54,051,183...54,055,658
Ensembl chr13:54,051,183...54,055,705
|
|
G |
Drd2 |
dopamine receptor D2 |
decreases expression affects response to substance increases activity increases expression multiple interactions affects expression decreases response to substance increases response to substance |
ISO EXP |
Cocaine results in decreased expression of DRD2 mRNA; Cocaine results in decreased expression of DRD2 protein DRD2 protein affects the susceptibility to Cocaine Cocaine results in increased activity of DRD2 protein Cocaine results in increased expression of DRD2 mRNA; Cocaine results in increased expression of DRD2 protein Cocaine affects the reaction [Spiperone binds to DRD2 protein]; Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]; Methadone affects the reaction [Cocaine affects the expression of DRD2 mRNA]; Spiperone inhibits the reaction [Cocaine promotes the reaction [[DRD2 protein results in increased phosphorylation of TH protein] which results in increased abundance of Dopamine]] Cocaine affects the expression of DRD2; Cocaine affects the expression of DRD2 mRNA; Cocaine affects the expression of DRD2 protein DRD2 protein results in decreased susceptibility to Cocaine PDYN protein affects the reaction [Cocaine affects the expression of DRD2 protein] DRD2 results in increased susceptibility to Cocaine DRD2 polymorphism results in increased susceptibility to Cocaine Cocaine affects the reaction [Raclopride binds to DRD2] |
CTD |
PMID:2213551 PMID:9892293 PMID:11126397 PMID:11602327 PMID:11790512 PMID:11923462 PMID:12892653 PMID:15010698 PMID:15042275 PMID:15049517 PMID:17161392 PMID:17532787 PMID:17544385 PMID:17671965 PMID:18000554 PMID:18305460 PMID:18990547 PMID:19046384 PMID:19723785 PMID:20435100 PMID:20729865 |
|
NCBI chr 9:49,340,360...49,408,177
Ensembl chr 9:49,340,627...49,408,177
|
|
G |
Drd3 |
dopamine receptor D3 |
decreases expression decreases response to substance increases expression increases activity affects expression affects activity multiple interactions affects response to substance |
ISO EXP |
Cocaine results in decreased expression of DRD3 protein DRD3 results in decreased susceptibility to Cocaine Cocaine results in increased expression of DRD3 mRNA Cocaine results in increased activity of DRD3 protein Cocaine affects the expression of DRD3 protein Cocaine affects the activity of DRD3 protein DRD3 protein results in decreased susceptibility to Cocaine 7-hydroxy-2-N,N-dipropylaminotetralin inhibits the reaction [Cocaine affects the activity of DRD3 protein]; Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]; KN 93 inhibits the reaction [Cocaine promotes the reaction [DRD3 protein binds to CAMK2A protein]] DRD3 affects the susceptibility to Cocaine [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD3 protein] which results in decreased susceptibility to Cocaine; [3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol co-treated with Cocaine] affects the localization of DRD3 protein; Cocaine promotes the reaction [DRD3 protein results in decreased expression of FOS protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of NEO1 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of PDYN protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of SYT7 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased phosphorylation of and results in decreased activity of MAPK1 protein]; Cocaine promotes the reaction [DRD3 protein results in decreased phosphorylation of and results in decreased activity of MAPK3 protein]; DRD3 protein affects the reaction [Cocaine results in increased expression of NTS mRNA]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of PDYN protein]; SB 277011 inhibits the reaction [[3,4,4a,10b-tetrahydro-4-propyl-2H,5H-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol binds to and results in increased activity of DRD3 protein] which results in decreased susceptibility to Cocaine] |
CTD |
PMID:10523822 PMID:10943692 PMID:11120399 PMID:12099907 PMID:15056714 PMID:15100700 PMID:16026479 PMID:18566292 PMID:19046384 PMID:19217379 PMID:19723785 PMID:20435100 PMID:20456009 |
|
NCBI chr16:43,754,015...43,825,982
Ensembl chr16:43,754,026...43,822,932
|
|
G |
Drd4 |
dopamine receptor D4 |
increases response to substance affects expression |
ISO |
DRD4 polymorphism results in increased susceptibility to Cocaine Cocaine affects the expression of DRD4 mRNA |
CTD |
PMID:17671965 PMID:20187946 |
|
NCBI chr 7:141,291,974...141,296,464
Ensembl chr 7:141,292,006...141,296,464
|
|
G |
Drd5 |
dopamine receptor D5 |
affects expression |
ISO |
Cocaine affects the expression of DRD5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:38,319,509...38,322,523
Ensembl chr 5:38,319,367...38,322,518
|
|
G |
Drp2 |
dystrophin related protein 2 |
affects expression |
ISO |
Cocaine affects the expression of DRP2 protein |
CTD |
PMID:19393250 |
|
NCBI chr X:134,404,124...134,456,574
Ensembl chr X:134,404,551...134,456,573
|
|
G |
Dsp |
desmoplakin |
increases expression |
ISO |
Cocaine results in increased expression of DSP protein |
CTD |
PMID:17075605 |
|
NCBI chr13:38,151,294...38,198,577
Ensembl chr13:38,151,294...38,198,577
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
affects expression increases phosphorylation |
ISO |
Cocaine affects the expression of DUSP1 mRNA Cocaine results in increased phosphorylation of DUSP1 protein |
CTD |
PMID:18822274 PMID:20187946 |
|
NCBI chr17:26,505,591...26,508,472
Ensembl chr17:26,505,590...26,562,128
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
affects expression increases expression |
ISO |
Cocaine affects the expression of CPG21 mRNA Cocaine results in increased expression of DUSP5 mRNA |
CTD |
PMID:20187946 PMID:27899881 |
|
NCBI chr19:53,529,145...53,541,809
Ensembl chr19:53,529,109...53,542,431
|
|
G |
Dusp8 |
dual specificity phosphatase 8 |
multiple interactions increases expression |
ISO |
5,7-Dihydroxytryptamine inhibits the reaction [Cocaine results in increased expression of DUSP8 mRNA] |
CTD |
PMID:9813294 |
|
NCBI chr 7:142,079,487...142,095,907
Ensembl chr 7:142,079,490...142,095,843
|
|
G |
Dvl1 |
dishevelled segment polarity protein 1 |
affects expression |
ISO |
Cocaine affects the expression of DVL1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 4:155,847,402...155,859,303
Ensembl chr 4:155,847,402...155,859,303
|
|
G |
Dync1i1 |
dynein cytoplasmic 1 intermediate chain 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of DYNC1I1 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 6:5,725,600...6,028,039
Ensembl chr 6:5,725,639...6,028,039
|
|
G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
increases expression |
ISO |
Cocaine results in increased expression of DYNC1LI2 protein |
CTD |
PMID:25100957 |
|
NCBI chr 8:104,417,674...104,443,050
Ensembl chr 8:104,417,680...104,443,047
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
affects expression |
ISO |
Cocaine affects the expression of DYNLL1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:115,297,110...115,300,990
Ensembl chr 5:115,297,110...115,300,999
|
|
G |
Eci2 |
enoyl-Coenzyme A delta isomerase 2 |
affects expression |
ISO |
Cocaine affects the expression of PECI mRNA |
CTD |
PMID:20187946 |
|
NCBI chr13:34,977,748...35,027,115
Ensembl chr13:34,977,748...35,027,096
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
Cocaine results in increased expression of EDN1 protein |
CTD |
PMID:9714087 PMID:11948058 PMID:17420087 PMID:18813882 |
|
NCBI chr13:42,301,476...42,307,990
Ensembl chr13:42,301,476...42,307,990
|
|
G |
Ednra |
endothelin receptor type A |
increases expression |
ISO |
Cocaine results in increased expression of EDNRA protein |
CTD |
PMID:17420087 PMID:18813882 |
|
NCBI chr 8:77,663,029...77,724,452
Ensembl chr 8:77,663,031...77,724,464
|
|
G |
Ednrb |
endothelin receptor type B |
affects expression |
ISO |
Cocaine affects the expression of EDNRB mRNA |
CTD |
PMID:20187946 |
|
NCBI chr14:103,814,615...103,844,508
Ensembl chr14:103,814,625...103,844,402
|
|
G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
affects expression |
ISO |
Cocaine affects the expression of EEF1A1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:78,478,453...78,481,724
Ensembl chr 9:78,478,449...78,489,151
|
|
G |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
affects expression |
ISO |
Cocaine affects the expression of EEF1A2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:181,141,758...181,157,015
Ensembl chr 2:181,147,653...181,157,014
|
|
G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
decreases expression |
ISO |
Cocaine results in decreased expression of EEF1G mRNA |
CTD |
PMID:15009677 |
|
NCBI chr19:8,967,041...8,978,180
Ensembl chr19:8,967,041...8,978,479
|
|
G |
Efcab3 |
EF-hand calcium binding domain 3 |
affects expression decreases expression |
ISO |
Cocaine affects the expression of EFCAB3 mRNA Cocaine results in decreased expression of EFCAB3 mRNA |
CTD |
PMID:17898221 PMID:20187946 |
|
NCBI chr11:105,008,985...105,117,537
Ensembl chr11:105,063,592...105,117,537
|
|
G |
Efna1 |
ephrin A1 |
affects expression |
ISO |
Cocaine affects the expression of EFNA1 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 3:89,271,730...89,280,951
Ensembl chr 3:89,271,733...89,281,142
|
|
G |
Efna2 |
ephrin A2 |
affects expression |
ISO |
Cocaine affects the expression of EFNA2 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr10:80,179,482...80,190,010
Ensembl chr10:80,179,482...80,190,010
|
|
G |
Efna3 |
ephrin A3 |
affects expression |
ISO |
Cocaine affects the expression of EFNA3 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 3:89,313,899...89,322,939
Ensembl chr 3:89,313,899...89,322,965
|
|
G |
Efna4 |
ephrin A4 |
affects expression |
ISO |
Cocaine affects the expression of EFNA4 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 3:89,333,393...89,338,028
Ensembl chr 3:89,333,390...89,338,028
|
|
G |
Efna5 |
ephrin A5 |
increases expression |
ISO |
Cocaine results in increased expression of EFNA5 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr17:62,602,957...62,881,317
Ensembl chr17:62,604,184...62,881,317
|
|
G |
Efnb1 |
ephrin B1 |
increases expression |
ISO |
Cocaine results in increased expression of EFNB1 mRNA |
CTD |
PMID:15691709 PMID:17898221 |
|
NCBI chr X:99,136,061...99,149,022
Ensembl chr X:99,136,130...99,148,991
|
|
G |
Efnb2 |
ephrin B2 |
increases expression |
ISO |
Cocaine results in increased expression of EFNB2 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 8:8,617,235...8,661,242
Ensembl chr 8:8,617,434...8,661,242
|
|
G |
Efnb3 |
ephrin B3 |
increases expression |
ISO |
Cocaine results in increased expression of EFNB3 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr11:69,554,092...69,561,150
Ensembl chr11:69,554,092...69,560,205
|
|
G |
Eftud2 |
elongation factor Tu GTP binding domain containing 2 |
affects expression |
ISO |
Cocaine affects the expression of EFTUD2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:102,838,472...102,880,984
Ensembl chr11:102,838,473...102,880,985
|
|
G |
Egfr |
epidermal growth factor receptor |
decreases expression |
ISO |
Cocaine results in decreased expression of EGFR mRNA |
CTD |
PMID:18000554 |
|
NCBI chr11:16,752,203...16,913,907
Ensembl chr11:16,752,203...16,918,158
|
|
G |
Egr1 |
early growth response 1 |
affects expression increases expression multiple interactions increases response to substance |
EXP ISO |
Cocaine affects the expression of EGR1 mRNA Cocaine results in increased expression of EGR1 protein NPPC protein inhibits the reaction [Cocaine results in increased expression of EGR1 mRNA] Cocaine results in increased expression of EGR1 mRNA; Cocaine results in increased expression of EGR1 protein EGR1 results in increased susceptibility to Cocaine [Cocaine co-treated with Caffeine] results in increased expression of EGR1 mRNA; Cocaine promotes the reaction [Caffeine results in increased expression of EGR1 mRNA] |
CTD |
PMID:1347779 PMID:7905595 PMID:9890435 PMID:10971643 PMID:11860464 PMID:16339038 PMID:16459018 PMID:16738229 PMID:17851536 PMID:18311559 PMID:18355967 PMID:20187946 |
|
NCBI chr18:34,861,207...34,864,956
Ensembl chr18:34,859,823...34,864,984
|
|
G |
Egr2 |
early growth response 2 |
increases expression affects expression |
EXP ISO |
Cocaine results in increased expression of EGR2 mRNA Cocaine affects the expression of EGR2 mRNA |
CTD |
PMID:20056891 PMID:20187946 PMID:27899881 |
|
NCBI chr10:67,534,469...67,542,188
Ensembl chr10:67,535,475...67,542,188
|
|
G |
Egr3 |
early growth response 3 |
affects expression multiple interactions increases expression |
ISO |
Cocaine affects the expression of EGR3 mRNA [Cocaine co-treated with Cocaine deficiency] promotes the reaction [RUNX2 protein binds to EGR3 promoter] Cocaine results in increased expression of EGR3 mRNA |
CTD |
PMID:16459018 PMID:20187946 PMID:30158054 |
|
NCBI chr14:70,077,317...70,082,613
Ensembl chr14:70,077,203...70,082,614
|
|
G |
Egr4 |
early growth response 4 |
increases expression |
ISO |
Cocaine results in increased expression of EGR4 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 6:85,511,121...85,513,589
Ensembl chr 6:85,511,121...85,513,589
|
|
G |
Ehd2 |
EH-domain containing 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of EHD2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 7:15,946,963...15,967,535
Ensembl chr 7:15,946,958...15,967,567
|
|
G |
Ehmt1 |
euchromatic histone methyltransferase 1 |
decreases expression |
EXP |
Cocaine results in decreased expression of EHMT1 mRNA |
CTD |
PMID:20056891 |
|
NCBI chr 2:24,790,769...24,919,643
Ensembl chr 2:24,789,928...24,919,614
|
|
G |
Ehmt2 |
euchromatic histone lysine N-methyltransferase 2 |
multiple interactions decreases response to substance decreases expression |
EXP |
Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ATM mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TGFBR1 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of TNFRSF25 mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of USP9X mRNA]; EHMT2 inhibits the reaction [Cocaine results in increased expression of WNK3 mRNA]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA] EHMT2 results in decreased susceptibility to Cocaine Cocaine results in decreased expression of EHMT2 mRNA; Cocaine results in decreased expression of EHMT2 protein |
CTD |
PMID:20056891 |
|
NCBI chr17:34,898,463...34,914,073
Ensembl chr17:34,898,469...34,914,052
|
|
G |
Eif1a |
eukaryotic translation initiation factor 1A |
increases expression |
ISO |
Cocaine results in increased expression of EIF1A mRNA |
CTD |
PMID:17898221 |
|
NCBI chr18:46,597,704...46,610,225
Ensembl chr18:46,597,701...46,616,456
|
|
G |
Eif1ax |
eukaryotic translation initiation factor 1A, X-linked |
increases expression |
ISO |
Cocaine results in increased expression of EIF1AY mRNA |
CTD |
PMID:17898221 |
|
NCBI chr X:159,372,178...159,389,621
Ensembl chr X:159,372,178...159,389,928
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions |
ISO |
Cocaine results in increased expression of EIF2AK3 protein 6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of EIF2AK3 protein] |
CTD |
PMID:17303341 |
|
NCBI chr 6:70,844,484...70,905,241
Ensembl chr 6:70,844,515...70,905,245
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
increases phosphorylation |
ISO |
Cocaine results in increased phosphorylation of EIF2S1 |
CTD |
PMID:18593214 |
|
NCBI chr12:78,862,072...78,887,010
Ensembl chr12:78,861,819...78,887,010
|
|
G |
Eif3a |
eukaryotic translation initiation factor 3, subunit A |
increases expression |
ISO |
Cocaine results in increased expression of EIF3A mRNA |
CTD |
PMID:17898221 |
|
NCBI chr19:60,761,116...60,790,693
Ensembl chr19:60,761,117...60,790,658
|
|
G |
Eif3b |
eukaryotic translation initiation factor 3, subunit B |
affects expression |
ISO |
Cocaine affects the expression of EIF3B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:140,419,305...140,443,358
Ensembl chr 5:140,419,328...140,443,360
|
|
G |
Eif3c |
eukaryotic translation initiation factor 3, subunit C |
increases expression |
ISO |
Cocaine results in increased expression of EIF3C mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 7:126,546,911...126,566,366
Ensembl chr 7:126,546,455...126,566,411
|
|
G |
Eif3e |
eukaryotic translation initiation factor 3, subunit E |
affects expression |
ISO |
Cocaine affects the expression of EIF3E mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:43,250,040...43,282,736
Ensembl chr15:43,250,058...43,282,719
|
|
G |
Eif4b |
eukaryotic translation initiation factor 4B |
multiple interactions increases expression |
EXP |
FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of EIF4B mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr15:102,073,773...102,097,173
Ensembl chr15:102,073,773...102,097,173
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
decreases expression affects expression increases expression |
ISO |
Cocaine results in decreased expression of EIF5A mRNA Cocaine affects the expression of EIF5A mRNA Cocaine results in increased expression of EIF5A mRNA |
CTD |
PMID:15009677 PMID:16710320 PMID:20187946 |
|
NCBI chr11:69,916,712...69,921,958
Ensembl chr11:69,916,714...69,921,958
|
|
G |
Eif5b |
eukaryotic translation initiation factor 5B |
increases expression |
ISO |
Cocaine results in increased expression of EIF5B mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:37,998,010...38,055,579
Ensembl chr 1:37,998,010...38,055,579
|
|
G |
Elane |
elastase, neutrophil expressed |
multiple interactions |
ISO |
[Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to ELANE protein]] which results in decreased activity of ELANE protein; Cocaine affects the reaction [Antibodies, Antineutrophil Cytoplasmic binds to ELANE protein] |
CTD |
PMID:18438818 |
|
NCBI chr10:79,886,312...79,888,216
Ensembl chr10:79,886,247...79,888,215
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
multiple interactions increases expression |
EXP |
EHMT2 inhibits the reaction [Cocaine results in increased expression of ELMO1 mRNA] |
CTD |
PMID:20056891 |
|
NCBI chr13:20,090,507...20,608,353
Ensembl chr13:20,090,596...20,608,353
|
|
G |
Emc9 |
ER membrane protein complex subunit 9 |
affects expression |
ISO |
Cocaine affects the expression of EMC9 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr14:55,581,519...55,585,375
Ensembl chr14:55,581,516...55,585,302
|
|
G |
Enah |
ENAH actin regulator |
increases expression |
ISO |
Cocaine results in increased expression of ENAH mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:181,896,384...182,027,556
Ensembl chr 1:181,896,384...182,019,990
|
|
G |
Enc1 |
ectodermal-neural cortex 1 |
increases expression |
ISO |
Cocaine results in increased expression of ENC1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr13:97,241,105...97,253,040
Ensembl chr13:97,241,105...97,253,034
|
|
G |
Enho |
energy homeostasis associated |
decreases expression |
ISO |
Cocaine results in decreased expression of ENHO mRNA |
CTD |
PMID:16710320 |
|
NCBI chr 4:41,638,144...41,640,302
Ensembl chr 4:41,638,144...41,640,324
|
|
G |
Eno2 |
enolase 2, gamma neuronal |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of ENO2 mRNA Cocaine results in increased expression of ENO2 protein |
CTD |
PMID:12629581 PMID:17075605 |
|
NCBI chr 6:124,760,053...124,769,673
Ensembl chr 6:124,760,053...124,769,673
|
|
G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase 5 |
increases expression |
ISO |
Cocaine results in increased expression of ENPP5 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr17:44,078,802...44,086,567
Ensembl chr17:44,078,813...44,086,567
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of ENTPD2 protein |
CTD |
PMID:25100957 |
|
NCBI chr 2:25,395,874...25,401,323
Ensembl chr 2:25,395,874...25,401,321
|
|
G |
Entpd3 |
ectonucleoside triphosphate diphosphohydrolase 3 |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of ENTPD3 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr 9:120,539,818...120,568,327
Ensembl chr 9:120,539,818...120,568,327
|
|
G |
Epha1 |
Eph receptor A1 |
affects expression |
ISO |
Cocaine affects the expression of EPHA1 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 6:42,358,487...42,373,314
Ensembl chr 6:42,358,487...42,373,268
|
|
G |
Epha2 |
Eph receptor A2 |
affects expression |
ISO |
Cocaine affects the expression of EPHA2 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 4:141,301,221...141,329,384
Ensembl chr 4:141,301,240...141,329,384
|
|
G |
Epha3 |
Eph receptor A3 |
affects expression |
ISO |
Cocaine affects the expression of EPHA3 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr16:63,543,532...63,864,175
Ensembl chr16:63,543,534...63,864,175
|
|
G |
Epha4 |
Eph receptor A4 |
affects expression increases expression |
ISO |
Cocaine affects the expression of EPHA4 mRNA Cocaine results in increased expression of EPHA4 mRNA |
CTD |
PMID:15691709 PMID:17898221 |
|
NCBI chr 1:77,367,182...77,515,107
Ensembl chr 1:77,367,185...77,515,088
|
|
G |
Epha5 |
Eph receptor A5 |
affects expression |
ISO |
Cocaine affects the expression of EPHA5 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 5:84,054,761...84,417,818
Ensembl chr 5:84,054,761...84,417,382
|
|
G |
Epha7 |
Eph receptor A7 |
affects expression |
ISO |
Cocaine affects the expression of EPHA7 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 4:28,813,066...28,967,503
Ensembl chr 4:28,813,131...28,967,499
|
|
G |
Epha8 |
Eph receptor A8 |
affects expression |
ISO |
Cocaine affects the expression of EPHA8 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 4:136,929,419...136,956,859
Ensembl chr 4:136,929,419...136,956,816
|
|
G |
Ephb1 |
Eph receptor B1 |
increases expression |
EXP ISO |
Cocaine results in increased expression of EPHB1 protein Cocaine results in increased expression of EPHB1 mRNA |
CTD |
PMID:11146119 PMID:15691709 |
|
NCBI chr 9:101,922,128...102,354,693
Ensembl chr 9:101,922,128...102,354,693
|
|
G |
Ephb2 |
Eph receptor B2 |
increases expression |
ISO |
Cocaine results in increased expression of EPHB2 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 4:136,647,536...136,836,326
Ensembl chr 4:136,647,539...136,835,988
|
|
G |
Ephb3 |
Eph receptor B3 |
affects expression |
ISO |
Cocaine affects the expression of EPHB3 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr16:21,204,620...21,223,309
Ensembl chr16:21,204,755...21,223,305
|
|
G |
Ephb4 |
Eph receptor B4 |
decreases expression affects expression |
ISO |
Cocaine results in decreased expression of EPHB4 mRNA Cocaine affects the expression of EPHB4 mRNA |
CTD |
PMID:15691709 PMID:18000554 |
|
NCBI chr 5:137,350,109...137,374,522
Ensembl chr 5:137,350,109...137,378,669
|
|
G |
Ephb6 |
Eph receptor B6 |
affects expression |
ISO |
Cocaine affects the expression of EPHB6 mRNA |
CTD |
PMID:15691709 |
|
NCBI chr 6:41,603,834...41,620,509
Ensembl chr 6:41,605,482...41,620,509
|
|
G |
Erbin |
Erbb2 interacting protein |
multiple interactions |
EXP |
HDAC5 affects the reaction [Cocaine affects the expression of ERBIN mRNA] |
CTD |
PMID:17988634 |
|
NCBI chr13:103,818,786...103,920,586
Ensembl chr13:103,818,787...103,920,514
|
|
G |
Ern1 |
endoplasmic reticulum (ER) to nucleus signalling 1 |
multiple interactions increases expression |
ISO |
6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; N-phenyl-7-(hydroxyimino)cyclopropa(b)chromen-1a-carboxamide inhibits the reaction [Cocaine results in increased expression of ERN1 protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of ERN1 protein] |
CTD |
PMID:17303341 |
|
NCBI chr11:106,397,620...106,487,796
Ensembl chr11:106,394,650...106,487,852
|
|
G |
Ess2 |
ess-2 splicing factor |
decreases expression |
ISO |
Cocaine results in decreased expression of ESS2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr16:17,900,709...17,911,348
Ensembl chr16:17,900,709...17,911,348
|
|
G |
Etf1 |
eukaryotic translation termination factor 1 |
affects expression |
ISO |
Cocaine affects the expression of ETF1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr18:34,902,785...34,932,008
Ensembl chr18:34,902,785...34,932,007
|
|
G |
Etfa |
electron transferring flavoprotein, alpha polypeptide |
affects expression |
ISO |
Cocaine affects the expression of ETFA mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 9:55,454,436...55,512,243
Ensembl chr 9:55,454,508...55,512,243
|
|
G |
Exoc2 |
exocyst complex component 2 |
increases expression |
ISO |
Cocaine results in increased expression of EXOC2 protein |
CTD |
PMID:25100957 |
|
NCBI chr13:30,789,516...30,974,096
Ensembl chr13:30,813,919...30,974,093
|
|
G |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
increases expression |
ISO |
Cocaine results in increased expression of EYA1 mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 1:14,168,953...14,311,035
Ensembl chr 1:14,168,954...14,310,235
|
|
G |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
affects expression |
ISO |
Cocaine affects the expression of EYA2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:165,595,028...165,771,727
Ensembl chr 2:165,595,032...165,771,727
|
|
G |
Ezr |
ezrin |
decreases expression |
ISO |
Cocaine results in decreased expression of EZR mRNA |
CTD |
PMID:20948987 |
|
NCBI chr17:6,738,131...6,782,780
Ensembl chr17:6,738,041...6,782,784
|
|
G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
affects expression multiple interactions decreases expression |
ISO |
Cocaine affects the expression of FADD mRNA Raclopride affects the reaction [Cocaine affects the expression of FADD protein] Cocaine results in decreased expression of FADD protein modified form |
CTD |
PMID:18580876 |
|
NCBI chr 7:144,578,323...144,582,441
Ensembl chr 7:144,577,318...144,582,463
|
|
G |
Fahd1 |
fumarylacetoacetate hydrolase domain containing 1 |
increases expression |
ISO |
Cocaine results in increased expression of FAHD1 protein |
CTD |
PMID:25100957 |
|
NCBI chr17:24,848,896...24,850,302
Ensembl chr17:24,848,892...24,850,364
|
|
G |
Fahd2a |
fumarylacetoacetate hydrolase domain containing 2A |
affects expression |
ISO |
Cocaine affects the expression of FAHD2A protein |
CTD |
PMID:19393250 |
|
NCBI chr 2:127,436,215...127,444,571
Ensembl chr 2:127,436,215...127,444,565
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
affects expression |
EXP |
Cocaine affects the expression of FAIM mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 9:98,986,373...99,002,019
Ensembl chr 9:98,986,373...99,002,021
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
Cocaine results in increased expression of FAIM2 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr15:99,497,005...99,534,880
Ensembl chr15:99,497,012...99,528,165
|
|
G |
Fam155a |
family with sequence similarity 155, member A |
increases expression |
ISO |
Cocaine results in increased expression of FAM155A mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 8:9,206,006...9,773,329
Ensembl chr 8:9,205,902...9,771,161
|
|
G |
Fam184b |
family with sequence similarity 184, member B |
decreases expression |
ISO |
Cocaine results in decreased expression of FAM184B mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 5:45,529,705...45,639,501
Ensembl chr 5:45,529,705...45,639,614
|
|
G |
Fam20c |
FAM20C, golgi associated secretory pathway kinase |
affects expression |
ISO |
Cocaine affects the expression of FAM20C mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:138,755,081...138,810,063
Ensembl chr 5:138,754,514...138,810,077
|
|
G |
Fam78b |
family with sequence similarity 78, member B |
decreases expression |
ISO |
Cocaine results in decreased expression of FAM78B mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:166,999,851...167,091,302
Ensembl chr 1:167,001,417...167,091,302
|
|
G |
Fas |
Fas (TNF receptor superfamily member 6) |
increases expression |
ISO |
Cocaine results in increased expression of FAS mRNA |
CTD |
PMID:16710320 |
|
NCBI chr19:34,290,647...34,327,775
Ensembl chr19:34,290,666...34,327,772
|
|
G |
Fbxl3 |
F-box and leucine-rich repeat protein 3 |
increases expression |
ISO |
Cocaine results in increased expression of FBXL3 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr14:103,080,239...103,099,566
Ensembl chr14:103,080,239...103,099,566
|
|
G |
Fbxo46 |
F-box protein 46 |
affects expression |
ISO |
Cocaine affects the expression of FBXO46 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:19,119,859...19,138,261
Ensembl chr 7:19,119,859...19,140,172
|
|
G |
Fcgr2b |
Fc receptor, IgG, low affinity IIb |
decreases expression |
ISO |
Cocaine results in decreased expression of FCGR2B mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 1:170,960,558...170,976,071
Ensembl chr 1:170,958,617...170,976,547
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
ISO |
Cocaine results in increased expression of FDFT1 mRNA |
CTD |
PMID:17205118 |
|
NCBI chr14:63,145,150...63,181,687
Ensembl chr14:63,145,150...63,179,578
|
|
G |
Fev |
FEV transcription factor, ETS family member |
decreases expression |
ISO |
Cocaine results in decreased expression of FEV mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 1:74,881,501...74,885,473
Ensembl chr 1:74,881,509...74,885,419
|
|
G |
Fgd5 |
FYVE, RhoGEF and PH domain containing 5 |
increases expression |
ISO |
Cocaine results in increased expression of FGD5 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 6:91,978,827...92,076,005
Ensembl chr 6:91,978,878...92,076,004
|
|
G |
Fgf12 |
fibroblast growth factor 12 |
affects expression |
ISO |
Cocaine affects the expression of FGF12 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr16:28,157,783...28,753,243
Ensembl chr16:28,160,098...28,753,068
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of FGF2 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 3:37,348,477...37,410,106
Ensembl chr 3:37,348,346...37,410,108
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
increases expression |
ISO |
Cocaine results in increased expression of FGFR1 mRNA |
CTD |
PMID:16076954 |
|
NCBI chr 8:25,518,759...25,575,718
Ensembl chr 8:25,513,654...25,575,718
|
|
G |
Fh1 |
fumarate hydratase 1 |
affects expression |
ISO |
Cocaine affects the expression of FH1 protein |
CTD |
PMID:19393250 |
|
NCBI chr 1:175,601,378...175,625,635
Ensembl chr 1:175,600,374...175,625,635
|
|
G |
Fis1 |
fission, mitochondrial 1 |
increases expression |
EXP |
Cocaine results in increased expression of FIS1 mRNA |
CTD |
PMID:31494168 |
|
NCBI chr 5:136,953,275...136,966,234
Ensembl chr 5:136,953,275...136,966,234
|
|
G |
Fkbp1b |
FK506 binding protein 1b |
affects expression |
ISO |
Cocaine affects the expression of FKBP1B mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:4,833,176...4,841,573
Ensembl chr12:4,833,174...4,841,591
|
|
G |
Fkbpl |
FK506 binding protein-like |
affects expression |
ISO |
Cocaine affects the expression of FKBPL mRNA |
CTD |
PMID:20187946 |
|
NCBI chr17:34,644,814...34,646,817
Ensembl chr17:34,644,764...34,646,324
|
|
G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
increases expression |
ISO |
Cocaine results in increased expression of FLRT3 mRNA |
CTD |
PMID:18000554 |
|
NCBI chr 2:140,658,198...140,671,476
Ensembl chr 2:140,650,914...140,671,469
|
|
G |
Flywch1 |
FLYWCH-type zinc finger 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of FLYWCH1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr17:23,752,795...23,774,530
Ensembl chr17:23,752,793...23,771,602
|
|
G |
Fmr1 |
FMRP translational regulator 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of FMR1 mRNA |
CTD |
PMID:24810662 |
|
NCBI chr X:68,678,536...68,717,963
Ensembl chr X:68,678,541...68,717,963
|
|
G |
Fndc1 |
fibronectin type III domain containing 1 |
multiple interactions |
EXP |
[Cocaine co-treated with FOS protein mutant form] results in decreased expression of FNDC1 mRNA |
CTD |
PMID:18355967 |
|
NCBI chr17:7,738,569...7,827,340
Ensembl chr17:7,738,569...7,827,302
|
|
G |
Fndc5 |
fibronectin type III domain containing 5 |
affects expression |
ISO |
Cocaine affects the expression of FNDC5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 4:129,136,870...129,144,593
Ensembl chr 4:129,136,999...129,144,593
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions increases expression affects expression increases phosphorylation decreases response to substance increases activity decreases expression |
ISO EXP |
[Cocaine co-treated with SLC6A3 protein] results in increased expression of FOS protein; Cocaine inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS mRNA]; Cocaine inhibits the reaction [[Dopamine co-treated with SLC6A3 protein] results in increased expression of FOS protein] Cocaine results in increased expression of FOS mRNA; Cocaine results in increased expression of FOS protein Cocaine affects the expression of FOS mRNA; Cocaine affects the expression of FOS protein Cocaine results in increased phosphorylation of FOS protein [Morphine co-treated with Cocaine] affects the expression of FOS; [SCH 23390 binds to and results in decreased activity of DRD1 protein] inhibits the reaction [Cocaine results in increased expression of FOS protein]; Alcohols promotes the reaction [Cocaine results in increased expression of FOS protein]; Baclofen inhibits the reaction [Cocaine results in increased expression of FOS protein]; Chloral Hydrate inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine promotes the reaction [[SK&F 81297 co-treated with Quinpirole] results in increased expression of FOS protein]; Cocaine promotes the reaction [Cocaine results in increased expression of FOS mRNA]; Cocaine promotes the reaction [Ethanol results in increased expression of FOS protein]; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of FOS protein]; ecopipam inhibits the reaction [Cocaine results in increased expression of FOS protein]; Ethanol promotes the reaction [Cocaine results in increased expression of FOS protein]; Muscimol inhibits the reaction [Cocaine results in increased expression of FOS protein]; NPPC protein inhibits the reaction [Cocaine results in increased expression of FOS mRNA]; Reserpine inhibits the reaction [Cocaine results in increased expression of FOS protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOS protein]; Urethane inhibits the reaction [Cocaine results in increased expression of FOS protein]; volinanserin inhibits the reaction [Cocaine results in increased expression of FOS protein] FOS protein mutant form results in decreased susceptibility to Cocaine Cocaine results in increased activity of FOS protein Cocaine results in decreased expression of FOS protein [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of NEO1 protein; [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of PDYN protein; [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein] which affects the expression of SYT7 protein; [Cocaine co-treated with Caffeine] results in increased expression of FOS mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ATPAF1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of CD4 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of CORO7 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ENTPD3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of FNDC1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of ITPR1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of NEXN mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PBX2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PER1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PINX1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PKNOX2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PLPP1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of PRKCZ mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of SHANK3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of SYT9 mRNA; [Cocaine co-treated with FOS protein mutant form] results in decreased expression of THRA mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of ADGRA1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CAB39L mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CAMK1G mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of CBLN1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of GRIP1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of INA mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of LARGE1 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of NRIP3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of SATB2 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of SORCS3 mRNA; [Cocaine co-treated with FOS protein mutant form] results in increased expression of TENM4 mRNA; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOS protein; Baclofen inhibits the reaction [Cocaine results in increased expression of FOS protein]; CDK5R1 protein inhibits the reaction [Cocaine affects the expression of FOS mRNA]; CDK5R1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; CNR1 mutant form inhibits the reaction [Cocaine results in increased expression of FOS protein]; Cocaine promotes the reaction [Caffeine results in increased expression of FOS mRNA]; Cocaine promotes the reaction [DRD1 protein results in increased expression of FOS protein]; Cocaine promotes the reaction [DRD3 protein results in decreased expression of FOS protein]; cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Cocaine results in increased expression of FOS protein]; DRD3 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of BDNF mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of CALR mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of DLK2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of HOMER2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of HS3ST2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of MAPK11 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NCALD mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NPTXR mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NRN1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of PRKCA mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SATB1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of SEZ6L mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP1B3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ATP8B2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CLK1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of CTSB mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of EIF4B mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of GPC5 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of KCNT1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of KDM3A mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of LIN7B mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of LZTS3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of MEPCE mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NIT2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NOS3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PBX3 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PPP1R7 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PRPF18 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of PTPRV mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SBSN mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SYNE1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of SYT2 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of TSPOAP1 mRNA]; FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of ZFPM1 mRNA]; GPX1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of FOS protein]; N-methyl-3-(bis(4'-fluorophenyl)methoxy)tropane inhibits the reaction [Cocaine results in increased expression of FOS protein]; NTRK2 protein affects the reaction [Cocaine affects the expression of FOS protein]; prolinedithiocarbamate inhibits the reaction [Cocaine results in increased expression of FOS protein]; RPS6KA3 affects the reaction [Cocaine results in increased phosphorylation of FOS protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOS protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOS protein]; SL 327 inhibits the reaction [Cocaine results in increased activity of FOS protein]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOS mRNA]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOS protein] |
CTD |
PMID:1498673 PMID:2118661 PMID:7905595 PMID:10415707 PMID:10521585 PMID:10632609 PMID:10814832 PMID:10904129 PMID:10943692 PMID:10971643 PMID:11160452 PMID:11172061 PMID:11403691 PMID:11421588 PMID:11716816 PMID:11739600 PMID:11860464 PMID:11882344 PMID:12112414 PMID:12122080 PMID:12128156 PMID:12379259 PMID:12419516 PMID:12581847 PMID:12670717 PMID:12699766 PMID:12786985 PMID:12821175 PMID:14644470 PMID:14741756 PMID:15056714 PMID:15219685 PMID:15254092 PMID:15295023 PMID:15665076 PMID:15814102 PMID:16179556 PMID:16263220 PMID:16300424 PMID:16339038 PMID:16395306 PMID:16459018 PMID:16710312 PMID:16930414 PMID:16962079 PMID:17276011 PMID:17596442 PMID:17851536 PMID:18164822 PMID:18311559 PMID:18355967 PMID:18396266 PMID:18479823 PMID:18822274 PMID:18991842 PMID:19169671 PMID:19606084 PMID:19620976 PMID:20187946 PMID:20633205 PMID:20947769 PMID:25933444 PMID:27899881 PMID:31059705 |
|
NCBI chr12:85,473,890...85,477,274
Ensembl chr12:85,473,890...85,477,273
|
|
G |
Fosb |
FBJ osteosarcoma oncogene B |
increases expression multiple interactions affects expression |
ISO EXP |
Cocaine results in increased expression of FOSB protein DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein alternative form]; DRD1 protein affects the reaction [Cocaine results in increased expression of FOSB protein]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form]; SCH 23390 inhibits the reaction [Cocaine results in increased expression of FOSB protein] Cocaine results in increased expression of FOSB mRNA; Cocaine results in increased expression of FOSB protein; Cocaine results in increased expression of FOSB protein alternative form Cocaine affects the expression of FOSB mRNA; Cocaine affects the expression of FOSB protein [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSB protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSB protein; [JUND protein results in decreased activity of FOSB protein] which results in decreased susceptibility to Cocaine; Cocaine inhibits the reaction [Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]]; Cocaine promotes the reaction [EHMT2 protein binds to FOSB protein]; EHMT2 protein inhibits the reaction [Cocaine results in increased expression of FOSB mRNA]; N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form]; PPP1R1B gene mutant form inhibits the reaction [Cocaine results in increased expression of FOSB protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSB protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSB protein]; SL 327 inhibits the reaction [Cocaine results in increased expression of FOSB protein alternative form] |
CTD |
PMID:10103106 PMID:11391778 PMID:11739600 PMID:12417638 PMID:15056714 PMID:15814102 PMID:15926929 PMID:16263220 PMID:16674926 PMID:16710312 PMID:17898221 PMID:18293355 PMID:18355967 PMID:18822274 PMID:20056891 PMID:20633205 PMID:27899881 |
|
NCBI chr 7:19,302,696...19,310,118
Ensembl chr 7:19,302,696...19,310,051
|
|
G |
Fosl1 |
fos-like antigen 1 |
affects expression decreases expression |
ISO |
Cocaine affects the expression of FOSL1 mRNA Cocaine results in decreased expression of FOSL1 mRNA |
CTD |
PMID:12117546 PMID:12629581 |
|
NCBI chr19:5,447,698...5,455,938
Ensembl chr19:5,447,547...5,455,946
|
|
G |
Fosl2 |
fos-like antigen 2 |
multiple interactions decreases expression |
ISO EXP |
Cocaine promotes the reaction [JUN protein binds to FOSL2 protein] [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein; [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSL2 protein; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased expression of FOSL2 protein]; SL 327 inhibits the reaction [[Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased expression of FOSL2 protein] Cocaine results in decreased expression of FOSL2 protein |
CTD |
PMID:15056714 PMID:15814102 |
|
NCBI chr 5:32,136,472...32,157,840
Ensembl chr 5:32,135,801...32,157,842
|
|
G |
Foxc2 |
forkhead box C2 |
decreases expression |
ISO |
Cocaine results in decreased expression of FOXC2 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 8:121,116,171...121,118,895
Ensembl chr 8:121,116,171...121,118,895
|
|
G |
Foxo1 |
forkhead box O1 |
decreases expression |
ISO |
Cocaine results in decreased expression of FOXO1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 3:52,268,337...52,350,109
Ensembl chr 3:52,268,336...52,353,221
|
|
G |
Fras1 |
Fraser extracellular matrix complex subunit 1 |
increases expression |
ISO |
Cocaine results in increased expression of FRAS1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 5:96,373,777...96,784,733
Ensembl chr 5:96,373,955...96,784,728
|
|
G |
Frem2 |
Fras1 related extracellular matrix protein 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of FREM2 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 3:53,513,938...53,658,593
Ensembl chr 3:53,513,938...53,657,355
|
|
G |
Frmd5 |
FERM domain containing 5 |
decreases expression |
ISO |
Cocaine results in decreased expression of FRMD5 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:121,545,529...121,807,087
Ensembl chr 2:121,545,529...121,807,087
|
|
G |
Frs3 |
fibroblast growth factor receptor substrate 3 |
affects expression |
ISO |
Cocaine affects the expression of FRS3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr17:47,687,607...47,704,286
Ensembl chr17:47,689,030...47,704,286
|
|
G |
Fubp1 |
far upstream element (FUSE) binding protein 1 |
affects expression |
ISO |
Cocaine affects the expression of FUBP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 3:152,210,422...152,236,830
Ensembl chr 3:152,210,422...152,236,826
|
|
G |
Fut8 |
fucosyltransferase 8 |
affects expression |
ISO |
Cocaine affects the expression of FUT8 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:77,237,430...77,475,998
Ensembl chr12:77,238,125...77,476,338
|
|
G |
Fzd6 |
frizzled class receptor 6 |
affects expression |
ISO |
Cocaine affects the expression of FZD6 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr15:39,006,149...39,038,192
Ensembl chr15:39,006,034...39,038,188
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
increases expression |
ISO |
Cocaine results in increased expression of G6PD protein |
CTD |
PMID:25100957 |
|
NCBI chr X:74,409,483...74,428,880
Ensembl chr X:74,409,483...74,429,194
|
|
G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
affects expression increases expression decreases expression |
ISO |
Cocaine affects the expression of GABBR1 mRNA Cocaine results in increased expression of GABBR1 mRNA Cocaine results in decreased expression of GABBR1 mRNA |
CTD |
PMID:11793422 PMID:16076954 PMID:20187946 |
|
NCBI chr17:37,045,966...37,074,305
Ensembl chr17:37,045,966...37,075,067
|
|
G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
decreases phosphorylation |
ISO |
Cocaine results in decreased phosphorylation of GABBR2 protein |
CTD |
PMID:12716959 |
|
NCBI chr 4:46,662,318...46,991,714
Ensembl chr 4:46,662,305...46,991,873
|
|
G |
Gabra1 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1 |
affects expression multiple interactions |
ISO |
Cocaine affects the expression of GABRA1 protein Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] 1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] |
CTD |
PMID:20826313 PMID:23266428 PMID:32209479 |
|
NCBI chr11:42,130,939...42,183,066
Ensembl chr11:42,130,939...42,182,930
|
|
G |
Gabrb1 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 1 |
increases expression |
ISO |
Cocaine results in increased expression of GABRB1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 5:71,657,921...72,149,572
Ensembl chr 5:71,658,113...72,149,037
|
|
G |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
multiple interactions |
ISO |
1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:23266428 PMID:32209479 |
|
NCBI chr11:42,419,515...42,632,591
Ensembl chr11:42,419,757...42,629,028
|
|
G |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
affects expression multiple interactions |
ISO |
Cocaine affects the expression of GABRB3 mRNA Cocaine affects the phosphorylation of and affects the expression of GABRB3 protein |
CTD |
PMID:20187946 PMID:20826313 |
|
NCBI chr 7:57,590,518...57,828,802
Ensembl chr 7:57,419,692...57,828,802
|
|
G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
multiple interactions |
ISO |
1-(3-chlorophenyl)piperazine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; 3,4-Methylenedioxyamphetamine promotes the reaction [Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [1-(3-chlorophenyl)piperazine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine promotes the reaction [3,4-Methylenedioxyamphetamine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Cocaine results in decreased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein] Cocaine inhibits the reaction [gamma-Aminobutyric Acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]] |
CTD |
PMID:23266428 PMID:32209479 |
|
NCBI chr11:41,910,190...42,000,857
Ensembl chr11:41,910,203...42,000,857
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of GAD1 mRNA Cocaine results in increased expression of GAD1 protein |
CTD |
PMID:12629581 PMID:15295023 PMID:18611417 |
|
NCBI chr 2:70,561,303...70,602,014
Ensembl chr 2:70,553,072...70,602,014
|
|
G |
Gal |
galanin and GMAP prepropeptide |
multiple interactions |
EXP |
GAL protein inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK1 protein]; GAL protein inhibits the reaction [Cocaine results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:19099295 |
|
NCBI chr19:3,409,915...3,414,544
Ensembl chr19:3,409,915...3,414,544
|
|
G |
Galk1 |
galactokinase 1 |
affects expression |
ISO |
Cocaine affects the expression of GALK1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr11:116,008,357...116,012,719
Ensembl chr11:116,008,457...116,012,719
|
|
G |
Galnt1 |
polypeptide N-acetylgalactosaminyltransferase 1 |
increases expression |
ISO |
Cocaine results in increased expression of GALNT1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr18:24,205,321...24,286,816
Ensembl chr18:24,205,344...24,286,818
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
affects expression |
ISO |
Cocaine affects the expression of GALNT16 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr12:80,518,471...80,603,898
Ensembl chr12:80,518,277...80,630,972
|
|
G |
Gap43 |
growth associated protein 43 |
decreases expression |
ISO |
Cocaine results in decreased expression of GAP43 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr16:42,248,552...42,340,651
Ensembl chr16:42,248,442...42,340,651
|
|
G |
Gas2 |
growth arrest specific 2 |
affects expression |
EXP |
Cocaine affects the expression of GAS2 mRNA |
CTD |
PMID:15681117 |
|
NCBI chr 7:51,861,791...51,995,005
Ensembl chr 7:51,862,015...51,994,975
|
|
G |
Gcc1 |
golgi coiled coil 1 |
increases expression |
ISO |
Cocaine results in increased expression of GCC1 mRNA |
CTD |
PMID:17205118 |
|
NCBI chr 6:28,416,603...28,421,724
Ensembl chr 6:28,416,091...28,428,390
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of GCLC mRNA PRKCD protein affects the reaction [Cocaine results in increased expression of GCLC mRNA]; rottlerin promotes the reaction [Cocaine results in increased expression of GCLC mRNA] |
CTD |
PMID:30393195 |
|
NCBI chr 9:77,754,535...77,794,489
Ensembl chr 9:77,754,535...77,794,485
|
|
G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
affects expression increases expression multiple interactions |
ISO EXP |
Cocaine affects the expression of GCLM mRNA Cocaine results in increased expression of GCLM mRNA PRKCD protein affects the reaction [Cocaine results in increased expression of GCLM mRNA]; rottlerin promotes the reaction [Cocaine results in increased expression of GCLM mRNA] |
CTD |
PMID:20187946 PMID:30393195 |
|
NCBI chr 3:122,245,487...122,267,215
Ensembl chr 3:122,245,557...122,270,732
|
|
G |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
increases expression |
ISO |
Cocaine results in increased expression of GDAP1 protein |
CTD |
PMID:25100957 |
|
NCBI chr 1:17,145,373...17,164,271
Ensembl chr 1:17,145,362...17,164,271
|
|
G |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
decreases expression |
ISO |
Cocaine results in decreased expression of GDAP1L1 protein |
CTD |
PMID:25100957 |
|
NCBI chr 2:163,438,420...163,455,324
Ensembl chr 2:163,438,476...163,455,324
|
|
G |
Gdnf |
glial cell line derived neurotrophic factor |
decreases expression |
ISO |
Cocaine results in decreased expression of GDNF mRNA |
CTD |
PMID:14622243 |
|
NCBI chr15:7,810,048...7,837,580
Ensembl chr15:7,810,846...7,837,575
|
|
G |
Gem |
GTP binding protein (gene overexpressed in skeletal muscle) |
increases expression |
ISO |
Cocaine results in increased expression of GEM mRNA |
CTD |
PMID:15009677 |
|
NCBI chr 4:11,704,447...11,714,993
Ensembl chr 4:11,704,457...11,714,752
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression decreases expression affects expression |
ISO EXP |
Cocaine results in increased expression of GFAP protein Cocaine results in decreased expression of GFAP protein Cocaine affects the expression of GFAP mRNA; Cocaine affects the expression of GFAP protein |
CTD |
PMID:11391778 PMID:11882367 PMID:12670315 PMID:15814102 PMID:20187946 |
|
NCBI chr11:102,887,336...102,897,200
Ensembl chr11:102,887,336...102,900,912
|
|
G |
Gfra2 |
glial cell line derived neurotrophic factor family receptor alpha 2 |
affects expression |
ISO |
Cocaine affects the expression of GFRA2 mRNA |
CTD |
PMID:12358776 |
|
NCBI chr14:70,890,107...70,979,840
Ensembl chr14:70,890,120...70,979,838
|
|
G |
Gh |
growth hormone |
multiple interactions |
ISO |
Cocaine inhibits the reaction [Clonidine results in increased secretion of GH1 protein] Cocaine inhibits the reaction [4-hydroxybutyric acid results in increased secretion of GH1 protein]; Cocaine inhibits the reaction [Sodium Oxybate results in increased expression of GH1 protein] |
CTD |
PMID:9413023 PMID:10657535 PMID:15099682 |
|
NCBI chr11:106,300,261...106,303,703
Ensembl chr11:106,300,271...106,301,865
|
|
G |
Gid8 |
GID complex subunit 8 |
affects expression |
ISO |
Cocaine affects the expression of GID8 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 2:180,710,122...180,721,599
Ensembl chr 2:180,710,117...180,718,733
|
|
G |
Gimap1 |
GTPase, IMAP family member 1 |
affects expression |
ISO |
Cocaine affects the expression of GIMAP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:48,739,047...48,743,795
Ensembl chr 6:48,739,054...48,743,795
|
|
G |
Gimap5 |
GTPase, IMAP family member 5 |
affects expression |
ISO |
Cocaine affects the expression of GIMAP5 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:48,746,197...48,754,200
Ensembl chr 6:48,746,197...48,754,210
|
|
G |
Gins3 |
GINS complex subunit 3 (Psf3 homolog) |
decreases expression |
ISO |
Cocaine results in decreased expression of GINS3 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 8:95,633,559...95,645,059
Ensembl chr 8:95,633,453...95,645,060
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
affects expression |
ISO |
Cocaine affects the expression of GIPC1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 8:83,649,408...83,664,789
Ensembl chr 8:83,652,677...83,664,694
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
increases expression |
ISO |
Cocaine results in increased expression of GJA5 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 3:97,032,402...97,053,634
Ensembl chr 3:96,904,693...97,077,416
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
affects expression |
ISO |
Cocaine affects the expression of GJB1 mRNA; Cocaine affects the expression of GJB1 protein |
CTD |
PMID:10510198 |
|
NCBI chr X:101,376,376...101,385,629
Ensembl chr X:101,376,378...101,385,629
|
|
G |
Gjb2 |
gap junction protein, beta 2 |
decreases expression |
ISO |
Cocaine results in decreased expression of GJB2 mRNA |
CTD |
PMID:12629581 |
|
NCBI chr14:57,098,602...57,104,702
Ensembl chr14:57,098,600...57,104,702
|
|
G |
Gjb5 |
gap junction protein, beta 5 |
decreases expression |
ISO |
Cocaine results in decreased expression of GJB5 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 4:127,354,809...127,358,164
Ensembl chr 4:127,354,809...127,358,181
|
|
G |
Gjd2 |
gap junction protein, delta 2 |
affects expression |
ISO |
Cocaine affects the expression of GJD2 mRNA; Cocaine affects the expression of GJD2 protein |
CTD |
PMID:16138316 |
|
NCBI chr 2:114,009,601...114,014,378
Ensembl chr 2:114,009,601...114,013,619
|
|
G |
Gli2 |
GLI-Kruppel family member GLI2 |
decreases expression |
ISO |
Cocaine results in decreased expression of GLI2 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 1:118,834,061...119,054,405
Ensembl chr 1:118,834,132...119,053,619
|
|
G |
Glp2r |
glucagon-like peptide 2 receptor |
decreases expression |
ISO |
Cocaine results in decreased expression of GLP2R mRNA |
CTD |
PMID:17898221 |
|
NCBI chr11:67,664,156...67,771,184
Ensembl chr11:67,661,502...67,771,153
|
|
G |
Glra1 |
glycine receptor, alpha 1 subunit |
multiple interactions |
ISO |
Cocaine inhibits the reaction [Glycine results in increased activity of GLRA1 protein]; Dronabinol inhibits the reaction [Cocaine inhibits the reaction [Glycine results in increased activity of GLRA1 protein]] |
CTD |
PMID:32209479 |
|
NCBI chr11:55,514,239...55,608,198
Ensembl chr11:55,514,238...55,608,198
|
|
G |
Glrx3 |
glutaredoxin 3 |
affects expression |
ISO |
Cocaine affects the expression of GLRX3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:137,437,573...137,469,631
Ensembl chr 7:137,437,614...137,468,594
|
|
G |
Gm13889 |
predicted gene 13889 |
increases expression |
ISO |
Cocaine results in increased expression of RGD1564664 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 2:93,955,810...93,957,100
Ensembl chr 2:93,955,810...93,957,201
|
|
G |
Gm38521 |
predicted gene, 38521 |
decreases expression |
ISO |
Cocaine results in decreased expression of CCDC73 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 2:105,017,121...105,020,725
|
|
G |
Gm6614 |
predicted gene 6614 |
affects expression |
ISO |
Cocaine affects the expression of SLCO1A3 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:141,971,833...142,012,263
Ensembl chr 6:141,971,845...142,011,414
|
|
G |
Gnao1 |
guanine nucleotide binding protein, alpha O |
decreases expression multiple interactions |
ISO |
Cocaine results in decreased expression of GNAO1 mRNA [Cocaine affects the activity of PRKACA protein] which affects the phosphorylation of GNAO1 protein alternative form |
CTD |
PMID:12629581 PMID:19457111 |
|
NCBI chr 8:93,810,153...93,969,388
Ensembl chr 8:93,809,966...93,969,388
|
|
G |
Gnat1 |
guanine nucleotide binding protein, alpha transducing 1 |
increases expression |
ISO |
Cocaine results in increased expression of GNAT1 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 9:107,674,437...107,679,634
Ensembl chr 9:107,674,474...107,679,712
|
|
G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
decreases expression increases expression |
ISO |
Cocaine results in decreased expression of GNB1 mRNA Cocaine results in increased expression of GNB1 mRNA |
CTD |
PMID:12629581 PMID:16076954 |
|
NCBI chr 4:155,491,300...155,559,269
Ensembl chr 4:155,491,361...155,559,269
|
|
G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
affects expression |
ISO |
Cocaine affects the expression of GNB2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 5:137,528,127...137,533,449
Ensembl chr 5:137,528,127...137,533,510
|
|
G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
multiple interactions |
EXP |
HDAC5 affects the reaction [Cocaine affects the expression of GNB4 mRNA] |
CTD |
PMID:17988634 |
|
NCBI chr 3:32,578,587...32,616,673
Ensembl chr 3:32,580,332...32,616,585
|
|
G |
Gng12 |
guanine nucleotide binding protein (G protein), gamma 12 |
affects expression |
ISO |
Cocaine affects the expression of GNG12 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 6:66,896,397...67,021,361
Ensembl chr 6:66,896,397...67,021,350
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
decreases expression multiple interactions |
EXP |
Cocaine results in decreased expression of GNRH1 protein GPX1 protein inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein]; prolinedithiocarbamate inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein] |
CTD |
PMID:31059705 |
|
NCBI chr14:67,745,181...67,749,440
Ensembl chr14:67,745,181...67,749,439
|
|
G |
Gp2 |
glycoprotein 2 (zymogen granule membrane) |
affects expression |
ISO |
Cocaine affects the expression of GP2 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 7:119,442,537...119,459,272
Ensembl chr 7:119,442,537...119,459,285
|
|
G |
Gpc5 |
glypican 5 |
increases expression multiple interactions |
EXP |
Cocaine results in increased expression of GPC5 mRNA FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of GPC5 mRNA] |
CTD |
PMID:18355967 |
|
NCBI chr14:115,092,201...116,525,192
Ensembl chr14:115,092,215...116,525,179
|
|
G |
Gper1 |
G protein-coupled estrogen receptor 1 |
increases expression |
ISO |
Cocaine results in increased expression of GPER1 mRNA |
CTD |
PMID:17898221 |
|
NCBI chr 5:139,423,150...139,427,800
Ensembl chr 5:139,423,151...139,427,800
|
|
G |
Gphn |
gephyrin |
increases phosphorylation multiple interactions |
ISO |
Cocaine results in increased phosphorylation of GPHN protein Win 55212-2 promotes the reaction [Cocaine results in increased phosphorylation of GPHN protein] |
CTD |
PMID:32312805 |
|
NCBI chr12:78,217,325...78,684,772
Ensembl chr12:78,226,379...78,684,772
|
|
G |
Gpm6a |
glycoprotein m6a |
decreases expression |
ISO |
Cocaine results in decreased expression of GPM6A mRNA |
CTD |
PMID:12629581 |
|
NCBI chr 8:54,779,434...55,060,878
Ensembl chr 8:54,954,843...55,060,871
|
|
G |
Gpm6b |
glycoprotein m6b |
decreases expression |
ISO |
Cocaine results in decreased expression of GPM6B mRNA |
CTD |
PMID:12629581 |
|
NCBI chr X:166,238,943...166,389,033
Ensembl chr X:166,238,911...166,388,988
|
|
G |
Gpr157 |
G protein-coupled receptor 157 |
decreases expression |
ISO |
Cocaine results in decreased expression of GPR157 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 4:150,087,503...150,105,927
Ensembl chr 4:150,087,365...150,105,927
|
|
G |
Gpr3 |
G-protein coupled receptor 3 |
increases expression |
ISO |
Cocaine results in increased expression of GPR3 mRNA |
CTD |
PMID:27899881 |
|
NCBI chr 4:133,209,340...133,212,536
Ensembl chr 4:133,209,340...133,212,536
|
|
G |
Gpr88 |
G-protein coupled receptor 88 |
affects expression |
ISO |
Cocaine affects the expression of GPR88 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr 3:116,249,654...116,253,540
Ensembl chr 3:116,249,654...116,253,503
|
|
G |
Gprasp1 |
G protein-coupled receptor associated sorting protein 1 |
affects expression |
ISO |
Cocaine affects the expression of GPRASP1 mRNA |
CTD |
PMID:20187946 |
|
NCBI chr X:135,742,692...135,803,468
Ensembl chr X:135,742,733...135,803,474
|
|
G |
Gpsm1 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) |
affects expression |
ISO |
Cocaine affects the expression of GPSM1 protein |
CTD |
PMID:15091342 |
|
NCBI chr 2:26,314,611...26,348,237
Ensembl chr 2:26,315,515...26,348,237
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions increases activity |
EXP |
PRKCD protein affects the reaction [Cocaine results in increased activity of GPT protein]; rottlerin inhibits the reaction [Cocaine results in increased activity of GPT protein] |
CTD |
PMID:30393195 |
|
NCBI chr15:76,696,726...76,699,675
Ensembl chr15:76,695,716...76,699,686
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression affects response to substance |
EXP |
GPX1 protein affects the susceptibility to [Cocaine co-treated with prolinedithiocarbamate]; GPX1 protein inhibits the reaction [Cocaine affects the localization of RELA protein]; GPX1 protein inhibits the reaction [Cocaine results in decreased expression of GNRH1 protein]; GPX1 protein inhibits the reaction [Cocaine results in increased activity of and affects the localization of RELA protein]; GPX1 protein inhibits the reaction [Cocaine results in increased expression of FOS protein]; prolinedithiocarbamate promotes the reaction [Cocaine results in increased expression of GPX1 protein] GPX1 protein affects the susceptibility to Cocaine |
CTD |
PMID:31059705 |
|
NCBI chr 9:108,339,080...108,340,342
Ensembl chr 9:108,338,903...108,340,343
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
increases expression |
ISO |
Cocaine results in increased expression of GRB2 protein |
CTD |
PMID:25100957 |
|
NCBI chr11:115,644,045...115,708,597
Ensembl chr11:115,644,045...115,708,597
|
|
G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
decreases response to substance decreases expression increases phosphorylation affects response to substance increases response to substance increases expression decreases phosphorylation multiple interactions affects expression |
EXP ISO |
GRIA1 results in decreased susceptibility to Cocaine Cocaine results in decreased expression of GRIA1 mRNA; Cocaine results in decreased expression of GRIA1 protein Cocaine results in increased phosphorylation of GRIA1 protein GRIA1 protein affects the susceptibility to Cocaine GRIA1 protein results in increased susceptibility to Cocaine GRIA1 protein mutant form results in decreased susceptibility to Cocaine; GRIA1 results in decreased susceptibility to Cocaine Cocaine results in increased expression of GRIA1 mRNA; Cocaine results in increased expression of GRIA1 protein Cocaine results in decreased phosphorylation of GRIA1 protein 6-methyl-2-(phenylethynyl)pyridine affects the reaction [Cocaine affects the phosphorylation of GRIA1 protein]; Cocaine affects the phosphorylation of and affects the expression of GRIA1 protein; Cocaine results in increased phosphorylation of and results in increased transport of GRIA1 protein; Dizocilpine Maleate inhibits the reaction [Cocaine results in increased expression of GRIA1 protein]; ifenprodil inhibits the reaction [Cocaine results in increased expression of GRIA1 protein]; ILK mutant form inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; Ondansetron inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; roscovitine inhibits the reaction [Cocaine results in decreased phosphorylation of GRIA1 protein]; U 0126 inhibits the reaction [Cocaine results in increased expression of GRIA1 protein] Cocaine affects the expression of GRIA1 mRNA; Cocaine affects the expression of GRIA1 protein Cocaine results in increased expression of and results in increased phosphorylation of GRIA1 protein; Nifedipine inhibits the reaction [Cocaine results in increased expression of and results in increased phosphorylation of GRIA1 protein]; resveratrol promotes the reaction [Cocaine results in increased phosphorylation of GRIA1 protein]; SL 327 inhibits the reaction [Cocaine results in increased phosphorylation of GRIA1 protein] |
CTD |
PMID:9886066 PMID:11268215 PMID:11801363 PMID:12511956 PMID:12787079 PMID:14684464 PMID:15140200 PMID:16473939 PMID:16794574 PMID:17680995 PMID:17898221 PMID:18278040 PMID:18430032 PMID:18701074< | |